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procedure and its dependency on the method used still remain largely unexplored. 
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1 INTRODUCTION 
 
1.1 Background 
 
Dry powder inhaler (DPI) is one of the main inhalation formulation alternatives to nebulizers 
and pressurized metered dose inhalers (pMDIs) for the delivery of the active pharmaceutical 
ingredients (API: s) into the human lungs (Newman et al. 2009). The basic composition of 
the DPI is the device with the packed powder formulation inside. In addition it may contain 
desiccants and possible inhalation aiding components such as compressed air. A DPI is 
considered as a quick and convenient device that is usually compact and portable. When 
compared with other formulation alternatives, it may be capable of delivering larger doses 
than pMDIs often with less variability in lung deposition and its aerosol is often formed 
solely due to an inhalation effort unlike in the other two types of devices. The DPI is 
considered to be a challenging device due to the interactions between the device, powder and 
patient (Bechtold-Peters et al. 2007).  
 
The powder formulation used in the DPI device provides certain benefits when compared to 
the other two formulations (Bechtold-Peters et al. 2007). A powder formulation is considered 
as relatively stable, easy to handle and allows relatively flexible drug dose adjustment. The 
stability of the formulation and stability against microbiological contaminants are considered 
as superior when compared to the wet formulations. The device does not usually need to be 
cleaned or sterilized during the usage. A DPI dose ranges from micrograms to several tens of 
milligrams in short time frames (Newman et al. 2009). The DPI powder can consist of plain 
API (Healy et al. 2008; Sansone et al. 2009) or API with excipients up to over 99% of the 
formulation (Newman et al. 2009). 
 
An optimal DPI formulation according to Chow et al. (2007) should have narrow 
aerodynamic particle size range, low surface energy and charge, non-spherical morphology, 
low density or high porosity as well as high physical and chemical stability. In addition to 
this it is considered as a rule that the particles are crystalline in nature to meet the stability 
requirements. To create a formulation with all these properties can be considered as 
challenging. The typical particle formation techniques include: micronization and blending, 
spray-drying, spray-freeze drying, emulsion based methods and supercritical antisolvents. For 
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various reasons none of these fills the above requirements fully, but they have acted as a basis 
for many formulation strategies.  
 
1.2 Spray drying 
 
Spray drying is a rapid powder producing technique that disperses and dries liquid feeds to 
produce particles (Masters 2002). It typically produces solid or low density amorphous 
powders (Chow et al. 2007) but can produce particles with narrow aerodynamic particle size 
distribution (Cabral-Marques and Almeida 2009), porosity (Healy et al. 2008), non-spherical 
particles (Gad et al. 2012) and crystalline solid state (Bianco et al. 2012). The capability to 
produce particles with these claimed optimal properties Chow et al. (2007) combined with 
the simplicity and rapidity of the spray drying process makes it a promising technique for 
inhalation particle production.   
 
The spray drying process itself has multiple variables (Buchi process parameters guide 2012) 
and the amount of variables increases even further when combined with the variables in the 
liquid feed (Masters 2002). This would theoretically allow the adjustment of the product 
quality quite efficiently. The challenges are the existence of significant interactions between 
different variables (Amaro et al. 2011; Gallo et al. 2011), the limited understanding on 
crystal growth, nucleation and supersaturated solutions (Vehring et al. 2007; Chen J. et al. 
2011) and the slight apparent product specific dependency of the variables (Gallo et al. 
2011). 
 
The solid state quality of a spray-dried product is generally said to be amorphous due to the 
short time frames (Masters 2002). Despite this statement several variables, such as 
temperature (Mezzena et al. 2009) and solid concentration (Alves and Santana 2004; Bianco 
et al. 2012) are claimed to produce crystalline material in organic solvent alone (Alves and 
Santana 2004; Bianco et al. 2012) or from a mixture combined with water (Mezzena et al. 
2009; Gad et al. 2011). Also other variables, such as feed rate (Islam and Langrish 2009), 
size of the nozzle orifice (Alves and Santana 2004), drying gas type (Islam and Langrish 
2010b; Bianco et al. 2012), level of insulation (Islam and Langrish 2010a) and drying 
pressure (Eslamian and Ashgriz 2006) are claimed to affect the solid state of the product. 
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This study is focused in creating more understanding on the spray drying process by the 
temperature, solid concentration and organic solvent/water -ratio regulation. These variables 
were chosen due to their effects on crystallization and other important properties. 
Temperature has been found to affect for example particle size, yield and morphology 
(Maltesen et al. 2008; Cheow et al. 2010; Amaro et al. 2011) and density (Masters 2002). 
Solid concentration was found to effect density (Masters 2002) and humidity (Burnett et al. 
2004) and organic solvent/water -ratio on particle size (Elversson and Millqvist-Fureby 
2005a; Bürki et al. 2011) and particle shape (Gad et al. 2011; Kaialy et al. 2010). 
 
 
2 BIOLOGICAL LIMITATIONS 
 
The respiratory tract comprises of three regions: the upper airways, the conducting airways 
and the respiratory airways (Newman et al. 2009). The upper airways heat and humidify 
inhaled air; the conducting airways are responsible for the air transportation to the respiratory 
airways, where the actual gas exchange will take place. The lungs can also be divided 
according to Weiber model into 24 airway generations (Weiber 1963 in Newman et al. 2009) 
(Fig. 1). In this model the airways from 0-16 are considered as conducting airways and 17-23 
as respiratory region composing of respiratory airways and finally ending into the alveolar 
sacs (generation 23) (Newman et al. 2009). The main function of the human lungs is to 
secure adequate oxygen levels in the blood circulation. In addition to this function it also acts 
as an excretion organ maintaining homeostasis. This includes the removal of excess carbon 
dioxide and when needed, some other unneeded and toxic volatile substances like inhalation 
anesthetics (Pleuvry et al. 2005) and ammonia (Tokuda et al. 2007). 
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Figure 1. The Weiber model (Patton and Byron 2007, modified from the original) 
 
From pulmonary drug delivery point of view the advantages are relatively large absorption 
area (approximately 100-190m2 in an adult individual), good blood perfusion (approximately 
5000ml/min, namely entire right sided cardiac output and partly also the left sided cardiac 
output), low metabolic activity and good permeability compared to other administration 
routes into the body (Newman et al. 2009). It also contributes to less systemic exposure and 
faster onset of drug action than for example oral route for lung diseases. Smaller metabolic 
exposure allows the use of lower effective dose, with even smaller systemic exposure and 
hence less side effects. Other advantages are the avoidance of injections and possibility to an 
alternative route for some drugs that are not absorbed via oral route.  
 
The limitations for pulmonary drug delivery are accessibility as the respiratory airways are 
nearly always also the desired place for drug deposition (Newman et al. 2009) and individual 
variability and efficacy (Bechtold-Peters et al. 2007). Absorption of the drug depends on the 
drug aerodynamic behavior, breathing pattern of patients, timing of aerosol injection into the 
breathing cycle and airway anatomy and morphology. The lungs are a challenging route for 
drug delivery having commonly less than 20% efficacy in delivery technologies and even 
500% individual variability. The API also has to reach the intended absorption site, to be 
absorbed and to avoid or delay the clearance of lungs (Newman et al. 2009). The clearance of 
lungs composes of: mucus movement towards throat, macrophages, enzymes, overall 
structure (turbulent flow, throat and tongue position) and coughing.  
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3 PARTICLE PROPERTIES RELEVANT FOR PULMONARY MEDICATION 
 
A dry powder inhaler composes of the device and the powder blend. The powder blend 
composes of API and possible one or more excipients depending on the formulation approach 
used (Bechtold-Peters et al. 2007). Currently there are three main formulation approaches 
used: classical interactive mixtures, agglomerated powders or special production techniques.  
 
The easiest way to formulate an inhalation powder is the classical interactive mixture 
approach (Bechtold-Peters et al. 2007). This includes a carrier substance, API and possibly 
additional excipients. A carrier substance is a larger-sized powder on to whose surface the 
smaller sized API will adhere (Newman et al. 2009). The most commonly used carrier is 
lactose monohydrate but in case of incompatibilities other crystalline sugars can also be 
considered (Bechtold-Peters et al. 2007). The challenges with this approach are dependent of 
API particle properties, carrier particle properties and blending related things. 
 
Agglomerated powder approach is used for high drug doses and products intended for 
reservoir inhalers with good metering properties (Bechtold-Peters et al. 2007). This approach 
includes formulating the micronized API into agglomerated soft spheres with controlled 
spheronization process. These spheres may compose of solely the API or it may be combined 
with small amount of micronized lactose. The benefits of this approach are the lack of 
problems associated with classical ordered mixtures, such as the carrier material quality 
issues (Bechtold-Peters et al. 2007), and the better flow properties than micronized particles 
(Newman et al. 2009). 
 
Special production techniques are used for high dose drugs and biotech compounds to 
produce diluent free directly used products (Bechtold-Peters et al. 2007). Typically the API 
and possible additives are spray-dried or freeze-dried to produce directly usable formulations. 
These types of formulations can for example be used for inhalation formulations (Bechtold-
Peters et al. 2007, Sansone et al. 2009). Additives that stabilize API and minimize 
incompatibilities may include mannitol or low molecular weight polymers like dextran 
(Bechtold-Peters et al. 2007; Elversson and Millqvist-Fureby 2005b).  
 
Regardless of the approach used there are some general requirements that can be listed for the 
inhalable particles that reach the lungs. These requirements are based on the limitations of the 
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human body, issues related to the inhalation device functionality and the general stability 
(Newman et al. 2009). These particles can comprise of pure API or mixtures of API and 
excipients. These properties include: particle size, shape, surface morphology and solid state 
properties. The drug/carrier ratio and the presence of other components as well as 
hygroscopicity, electrostatic forces and overall stability are factors that contribute to the 
performance and viability of the formulation.  
 
3.1 Particle size 
 
In order to penetrate into the lungs a particle has to be small enough, namely preferably 
smaller than 5 µm in geometric diameter (Newman et al. 2009). This is because of the 
physical limitations in the human lungs. The lower limit of the particle size is governed by 
the increased exhalation tendency of particles smaller than 1 µm and the increased surface 
area that facilitates dissolution (Elkordy et al. 2012; Faiyazuddin et al. 2012). A decrease in 
particle size also decreases the transport capacity of the spray cloud as smaller particles 
contain less substance (Newman et al. 2009). Particles smaller than 1 µm are considered 
nanoparticles (1-0.01 µm, Kreuter et al. 1994 via Sham et al. 2004). They start requiring 
additional means like carrier particles (Sham et al. 2004) or formulation techniques (Tsapis et 
al. 2002) to be effectively transported to the lungs.  
 
However, for pulmonary delivery geometric diameters can be slightly misleading. A better 
value to be used for an inhaled particle is the aerodynamic diameter (Da) that describes the 
aerodynamic behavior of a particle (Newman et al. 2009). It can be seen from Equation 1 that 
aerodynamic diameter for a spherical particle is affected by physical diameter (D) and 
specific gravity (density relative to water, 𝜌) of the particle. 
 
𝐷𝑎 = 𝐷�𝜌    (1) 
 
According to the Equation 1 particles that are denser than water (1 g/cm3) behave as if they 
would be larger than their physical size and lighter particles behave as if they would be 
smaller than their physical size (Newman et al. 2009). A spherical particle with a physical 
diameter of 5 µm and density of 0.25g/cm3 would behave aerodynamically similarly as 
2.5µm diameter water sphere. Particles of low density are advantageous because with their 
low aerodynamic diameter and relative large volume they are able to disperse better and 
7 
 
penetrate more efficiently into the deep lung (Platz et al. 2004). In addition they allow for 
escape from the natural phagocytic clearance in the lung and therefore increase 
bioavailability (Bechtold-Peters et al. 2007, Newman et al. 2009). This is due to their large 
geometric diameter that makes them too large for macrophages to engulf. These types of 
hollow particles can for example be produced with a spray dryer (Cheow et al. 2010). 
 
Particle deposition in lungs is a result of three mechanisms: inertial impaction, gravitational 
sedimentation and Brownian diffusion (Newman et al. 2009) (Fig. 2).  These mechanisms 
dominate different size bands. Inertial impaction dominates in the upper airways in areas 
where airstream changes its direction and can occur in inhalation or exhalation. The particle 
(between 1-10 µm) has too much inertia either because of large aerodynamic diameter or too 
fast speed and will not follow the airstream and hits the wall instead.  
 
 
 
Figure 2. Schematic of the three major deposition mechanisms for a particle in the respiratory 
tract. 
 
Gravitational sedimentation takes place in smaller conducting airways (Weibers model 
generations 8-16) and alveoli, where it is generally the dominant deposition process 
(Newman et al. 2009). It is caused by combination of gravitation and enough slow air flow 
during slow breathing or holding of breath. For example a 5µm particle with 1 g/cm3 density 
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has sedimentation rate of 0.74 mm/s causing it to deposit efficiently in 3 seconds breath 
holding in airways smaller than 2 mm diameter.  
 
Particles with diameters less than 1 µm are most likely to deposit by Brownian diffusion, 
taking place mainly in alveoli (Newman et al. 2009). These small particles have insufficient 
inertia for inertial impaction and their settling velocity is too small for gravitational 
sedimentation. Brownian diffusion means that the particles move by collisions with gas 
molecules (Bechtold-Peters et al. 2007). The movement being irregular and unoriented will 
cause the particle to deposit after undefined amount of time depending on probability. The 
size band of around 0.5 µm is an exception whereas in addition to the other deposition 
mechanisms, it is also little impacted by Brownian diffusion. Below this size band deposition 
rises again due to Brownian diffusion and other additional effects (Newman et al. 2009). For 
example particles of 100 nm will deposit throughout the respiratory tract of which 20% will 
deposit in the alveolar region (Schmid et al. 2009 via Zhang et al. 2011). The nanosized 
particles could possibly be highly beneficial due to their delayed clearance and relatively 
larger surface if efficiently delivered to the lungs (Bhavna et al. 2009).  
 
There are plenty of methods to measure the size of the inhalable particles. To measure the 
aerodynamic particle size, cascade impactors (CI:s) are preferred (Newman et al. 2009). A 
cascade impactor is a device that mimics the particle deposition in lungs as a function of their 
aerodynamic diameter, although geometric diameter is also postulated to contribute to the 
results (Vanbever et al. 1999).  The general idea is to fit the inhalator into a linearly 
connected sieving system with generated air flow. There are several different designs 
available like Andersen Cascade Impactor (ACI), Next Generation Impactor (NGI) and 
Multistage Liquid Impinger (MLI) (Newman et al. 2009). The sources of errors in CI can be 
the wearing down of the device, wall deposition, blockage in the system and particle 
bouncing from surfaces.  
 
To measure the geometric size a laser diffraction instrument or microscopic techniques can 
be used. The applicable range of a laser diffraction apparatus is around 0.1-1000 µm 
(Bechtold-Peters et al. 2007) but can even be 0,02-2000 µm (Rawle 2012). This makes it 
applicable for respiratory range sized particles (preferably 1- 5 µm diameters) (Bechtold-
Peters et al. 2007). There are, however, a few limitations with the laser diffraction. The 
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technology analyses a three dimensional particle and converts this knowledge into a one 
number that represents the dimensions of a particle (Rawle 2012). This description is valid 
only for a perfect sphere with a dimension of two times its range and not for a particle with 
random surface. Hence measured values are approximates. The increase in accuracy when the 
particles sphericity is increased is also supported by the studies of Martin et al. (2006). The 
microscopic techniques are considered accurate but skill demanding and time consuming 
(Newman et al. 2009). This is especially the case for traditional image analysis techniques. 
The microscopic devices include for example light microscopes and scanning electron 
microscopes (SEM). 
 
Particle size is an important value when determining substances performance as a pulmonary 
aerosol, though for pharmaceutical powders particle size distribution is usually preferred as a 
describing factor over particle size. This is due to the common heterodisperse nature of 
pharmaceutical powders (Newman et al. 2009). The terms Fine Particle Fraction (FPF) and 
Fine Particle Dose (FPD) are used to describe the inhalation related performance of the 
powder. The former is defined generally as the percentage of the aerosol drug mass contained 
in particles smaller than about 5 µm and the latter is defined as the dose of drug depositing in 
a Cascade Impactor (CI) in particles with aerodynamic diameters less than a stated size or in 
a specific size range.  
 
 
Figure 3. Deposition of places of different size brands in human respiratory tract (Patton and 
Byron 2007, modified from the original)  
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Different aerodynamic diameters can be used to target particles to different regions in the 
respiratory tract (Fig. 3) and some size bands (2-4 µm) even tend to be relatively independent 
on inhalation mode (Newman et al. 2009). To achieve best systemic delivery via lungs the 
low alveolar region is desired and particle sizes of probably 1-2 µm preferred (Chow et al. 
2007). Different-sized particles might also be used to treat different kind of symptoms 
(Faiyazuddin et al. 2012). A relatively monodisperse particles have been produced with 
spinning top aerosol generator (Biddiscombe et al. 2003) and spray drying (Chawla et al. 
1994; Cabral-Marques and Almeida 2009; Cheow et al. 2010; Xu et al. 2012). These types of 
particle size distributions would possibly allow more precise dosing of API.  
 
3.2 Shape and surface structure 
 
The diameter is a true definition only for spherical particles, whereas the non-spherical 
particles are represented with “apparent” diameters (Masters 2002). The apparent diameter is 
the mean distance between extremities of the particle measured through the centre of gravity 
of the particle. This, however, can make it difficult to evaluate and reproduce the results. For 
non-spherical particles the aerodynamic diameter is a value that defines the particle 
deposition mechanism (Chow et al. 2007) and hence is the most appropriate. 
 
The Equation 2 presents an estimate of the aerodynamic diameter (DA) for a non-spherical 
particle as the function of the following factors: the volume equivalent diameter (diameter of 
a sphere of equivalent volume, DV), the particle density (ρ), the unit density (density of 
spherical calibration spheres,ρ0) and the dynamic shape factor (defined as the ratio of the 
drag force on a particle to the drag force on the particle volume-equivalent sphere at the same 
velocity,χ), (Chow et al. 2007). The shape factor (χ) that is defined by size-measurements 
and approximations is seldom found useful (Masters 2002). A more useful technique is often 
some particle viewing technology (e.g. microscope) combined with in-house definitions. 
 
𝐷𝑎 ≅ 𝐷𝑉�
𝜌
𝜒𝜌0
     (2) 
 
It can be seen that decreasing the volume equivalent particle diameter (DV), reducing the 
particle density (ρ) or increasing the particle dynamic shape factor (χ) the aerodynamic 
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diameter can be decreased to a more favorable state (Chow et al. 2007). According to the 
Equation 2 an optimal particle would be small, non-spherical and hollow. One possible 
method for production would therefore be a spray dryer with optimized parameters (Masters 
2002).  
 
The overall shape of a particle is a combination of the macroscopic shape and the surface 
structure. The shape is presented as the shape factor (χ), but the surface structure is a 
considered as a combination of shape factor (χ) and particle density (ρ), (Chow et al. 2007). 
Both of these have been noted to affect the aerosol performance of a powder although it has 
been suggested that this effect is dependent on the efficacy of the inhaler used (Chan 2008). 
 
Many types of particles and surfaces have been produced and tested for inhalation purposes: 
round particles (Chawla et al. 1994), needle type particles (Larhrib et al. 2003), matrix type 
particles (Beinborn et al. 2012), hollow spherical particles (Vehring et al. 2007; Cheow et al. 
2010), spherical porous particles (Vanbever et al. 1999; Healy et al. 2008; Nolan et al. 2009; 
Gad et al. 2012), rod shaped crystals (Gad et al. 2012), spherical crystal clusters, differently 
shaped crystalline habits (Kubavat et al. 2012), spiked spherical particles (Raula et al. 2009), 
rough-surfaced spherical particles (Adi et al. 2013). Of these produced particles, round 
particles (Chawla et al. 1994) performance was equal with the micronized particles. The 
needle type particles (Larhrib et al. 2003), hollow spherical particles (Vehring et al. 2007), 
spherical porous particles (Nolan et al. 2009) and spiked spherical particles (Raula et al. 
2009) performed better than micronized particles. The rough-surfaced spherical particles (Adi 
et al. 2013) performed better than corresponding smooth particles. All results were not 
compared with the performance of other qualities but were instead verified to be suitable for 
inhalation purposes. There seem to be vast amount of different shapes to decrease the 
aerodynamic diameter of a particle. This indicates that currently there seems to be no one 
solution to amplify the aerosol performance by shape modification but several alternative 
solutions.  
 
The increase in surface roughness (Vehring 2008; Kawakami et al. 2010), the introduction of 
surface structures (Raula et al. 2009; Ghoroi et al. 2013) as well as introduction of pores 
(Healy et al. 2008; Newmann et al. 2009; Nolan et al. 2009; Nolan et al. 2011) all aim to 
reduced number of surface contact points, hence interparticle cohesive forces are minimized. 
This has been noted to increase de-agglomeration and fine particle fraction (FPF) (Adi et al. 
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2008; Weiler et al. 2010; Adi et al. 2013). They all also beneficially lower the aerodynamic 
diameter.  However, there might be a level of optimal surface roughness as is indicated by the 
study of surface asperities (Fig. 4), (Raula et al. 2009). Passing this optimal value might 
increase the interlocking of particles due to the increased shape fitting of corrugated surfaces 
(Raula et al. 2009; Weiler et al. 2010). These interlockings would be stronger for the more 
corrugated particles than for the less corrugated ones and could cause problems with 
aerosolisation. 
 
 
 
Figure 4. Illustration of particle contacts with different surface structures. (Raula et al. 2009, 
modified from the original). 
 
A preferred particle in respect to shape and surface structure is most likely a particle with 
small aerodynamic diameter and suitable amount of surface roughness (Weiler et al. 2010). 
In addition to these factors there are plenty of other factors that should be studied more 
closely in order to define the effect of the overall shape on aerosol behavior. These include 
the preferential particle orientation and characteristic particle rotation time that have been 
proposed to be important factors (Shekunov et al. 2007). 
 
3.3 Particle composition 
 
Dry powder inhalation formulation can be composed of the plain API (Healy et al. 2008; 
Sansone et al. 2009) or API combined with different excipients (Raula et al. 2009; Kubavat 
et al. 2012) or together with different APIs and excipients (Traini et al. 2012). The 
formulations containing more than one substance can either be formulated into same particles 
(Raula et al. 2009; Kumon et al. 2010) or mixed together to form interactive powder mixtures 
(Kubavat et al. 2012).  
 
Sole API particles have the benefit of not exposing the body to unneeded substances like 
excipients, part of which can theoretically be harmful (Healy et al. 2008). Also a higher 
payload of drug may be a more efficient way to deliver the drug especially if larger doses are 
needed (Muttil et al. 2007). The challenges remain in the production and process 
optimization (Sansone et al. 2009). The possible production can be performed for example 
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with spray drying (Bechtold-Peters et al. 2007; Healy et al. 2008; Nolan et al. 2009; Nolan et 
al. 2011; Sansone et al. 2009), controlled spheronization or freeze drying (Bechtold-Peters et 
al. 2007). 
 
More often the API is combined with excipients or other APIs to enhance its performance or 
stability (Muttil et al. 2007). They can also broaden the type of substances and the geometric 
size range that can be used.  For example the right excipients have made it possible to deliver 
large molecules like insulin (6000 Da) (Bechtold-Peters et al. 2007) and small nanoparticles 
to the lungs (Sham et al. 2004; Bhavna et al. 2009; Beck-Broichsitter et al. 2012). Examples 
in the protein stabilization include the addition of surfactants or simple sugars like mannitol 
into the formulation (Millqvist-Fureby et al. 1999). Surfactants like Tween 80 can displace 
the protein from the surface of the atomized droplet and thus preserve its activity. Simple 
sugars can improve stability and aerosol performance, depending on their physical state and 
concentration.  
 
The different components in the formulation can be applied to form layers over one another 
(Elversson and Millqvist-Fureby 2005b; Elversson and Millqvist-Fureby 2006; Buttini et al. 
2008b; Albertini et al. 2008) (Fig. 5, c), to form particles with a blend composition 
(Bosquillon et al. 2001; Kumon et al. 2010; Traini et al. 2012) (Fig. 5, a), to be mixed into an 
interactive or ordered mixture (Harjunen et al. 2002b) (Fig. 5, b) or to be a combination of 
some of the presented methods (Traini et al. 2012) (Fig. 5, d). The type and amount of the 
excipients and the formulation type has been noted to affect considerably on the aerosol 
performance of the powder (Bosquillon et al. 2001; Bechtold-Peters et al. 2007).  
 
 
 
Figure 5. Schematic drawing to illustrate the different component mixtures. 
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In an interactive mixture formulation the excipients crystallinity has been noted to increase 
the stability and flowability (Harjunen et al. 2002b). Size distribution that includes finer 
fractions has been noted to increase the emitted drug dose possibly due to the lower adhesion 
tendency (Harjunen et al. 2002b; Guenette et al. 2009; Kaialyet al. 2010). An increase in 
surface roughness has been noted to decrease the emitted drug dose. The shapes of needle 
(Kaialy et al. 2010) and pollen (Hassan and Lau 2011) have been tested as carrier particles 
with good results. As for the whole formulation type, decrease in density seems to also 
decrease the emitted dose of the API (Harjunen et al. 2002b).  
 
Combining all the components into blend particles seem to be an efficient way to deliver 
drugs (Muttil et al. 2007; Kumon et al. 2010), produce high fine particle fraction and 
improving dose uniformity (Tajber et al. 2009b). The addition of excipients has also been 
noted to extend the release of API (Muttil et al. 2007; Beck-Broichsitter et al. 2012). Another 
solution to perfect the design seems to be the addition of molecules that spontaneously 
accumulate on the particle surfaces, e.g. sodium dodecyl sulphate or PVP to modify it 
(Buttini et al. 2008b; Kawakami et al. 2010). 
 
The excipients used in a DPI formulation can include crystalline sugars (lactose, glucose, 
trehalose, sucrose, raffinose, mannitol), polymers (dextran, inulin) (Bechtold-Peters et al. 
2007), fluorocarbons, lung surfactant dipalmitoyl phoshatidylcholine (DPPC), fumaryl 
diketopiperazine (Newmann et al. 2009), poly lactic acid (LPA) (Muttil et al. 2007), poly 
vinyl alcohol (Buttini et al. 2008b) and others. Currently lactose is considered as the golden 
standard for inhalation excipient due to its inert nature, low cost and extensive use (Bechtold-
Peters et al. 2007). Especially it is used as a carrier in interactive powder mixtures. 
 
It appears that the larger amount of surfaces the excipient covers and the more excipient is 
used the more effect it has on the quality of the powder (Bechtold-Peters et al. 2007; 
Kawakami et al. 2010). The use of a multitude of excipients adds another variable that may 
be difficult to evaluate without experimental data on the specific case. Large amounts of 
excipients also make the emitted dose (ED) less dependent on the turn down ratio of the 
inhaler since the emitted dose is defined as the mass of API exiting the mouthpiece of an 
inhaler each time the inhaler is used (Newman et al. 2009). 
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3.4 Solid state properties 
 
A solid mass of API molecules packed together can form a three-dimensional long-range 
order that is considered as a crystalline structure or they can form an unoriented mass that is 
considered as an amorphous structure (Hancock and Zografi 1997). However, typically the 
amorphous structure forms short range orders over few molecular dimensions. It is possible 
that an API may form more than one different crystalline structure (polymorphism), each of 
which can in turn form different crystal shapes (crystal habits) (Stieger and Liebenberg, 
2012) (Fig. 6). 
 
 
 
Figure 6. Schematic representation of different solid state structures and crystal habits. 
 
 
As the crystallization is a process it takes time to be completed and is affected by many 
factors, such as temperature, saturation level and additives (Stieger and Liebenberg, 2012).  
The crystallization rate probably has optimal values below the melting point of a substance. 
Although rapid cooling and rapid evaporation have been noted to increase nucleation of 
molecules, which is the perquisite for crystal growth, processes like rapid precipitation from 
solution are said to promote formation of amorphous structure. Spray drying is an example of 
a rapid precipitation process from solution and it is said to produce amorphous quality 
material (Hancock and Zografi 1997). However, it is claimed that the level of crystallization 
may be adjusted by controlling the operation conditions (Chiou et al. 2008). Other examples 
to produce amorphous materials in pharmaceutical production include: vapour condensation, 
supercooling of melt and milling and compaction of tablets (Hancock and Zografi 1997).  
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Figure 7 shows the supercooling of melt as a function of temperature, volume and enthalpy. 
The temperatures (TK) (Tg) (Tm) are Kauzmann temperature, glass transition temperature and 
melting point. The TK is the theorethical limit for the Tg (Ediger et al. 1996), the Tm is the 
temperature where the crystalline/liquid transition takes place and the Tg is the temperature 
for liquid/amorphous transition (Hancock and Zografi 1997). Of these values the value Tg is 
not considered an exact value as it is found dependent on the thermal history of the sample 
and experimental conditions (Baird and Taylor 2012). It is rather considered as an indication 
of the area for transition region. The measurement of Tg may be challenging (Nolan et al. 
2011). 
 
 
Figure 7. Schematic representation of the supercooling of a melt (Hancock and Zografi 1997, 
modified from the original). 
 
When a liquid substance (Fig. 7) is cooled it first reaches the Tm and starts to crystallize and a 
decrease is seen in both volume and enthalpy (Hancock and Zografi 1997). Crystalline 
structures are considered as less energetic and highly stable when compared to amorphous 
structures. The possible existence of polymorphs adds another variable as each of them has 
unique physical properties and stability (Stieger and Liebenberg, 2012). The existence of 
different energy states creates a possibility for the amorphous product and other polymorphs 
for a transformation towards the most stable polymorph, if given the proper conditions. 
Therein the choice between the known polymorphs is often a compromise between stability 
and solubility to secure the best properties for pharmaceutical production. 
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If the cooling in Figure 7 is done rapidly the system may pass the Tm and become 
supercooled liquid (Hancock and Zografi 1997) or “rubbery” type material (Baird and Taylor 
2012). When the cooling is continued further to Tg many changes are observed in the physical 
properties of the cooled material. These include changes in viscosity, density, heat capacity, 
X-ray diffraction and diffusion. This new glassy state of material with the structural 
characteristics of a liquid but with considerably higher viscosity is considered as amorphous 
material (Hancock and Zografi 1997). Amorphous form is typical for polymeric molecules, 
large peptides and it can occur for small inorganic and organic molecules as well. The low 
molecular weight pharmaceuticals may form more fragile glasses than polymers (Craig et al. 
1999). 
 
As the amorphous material is relatively high energetic, a chance of crystallization is always 
present in handling and storage (Hancock and Zografi 1997), although amorphous materials 
are proposed to remain stable at their Kauzmann temperature or below it (Corrigan et al. 
2004). The considerably greater hygroscopicity of the amorphous material is further 
influencing its stability when compared with its crystalline counterparts (Nakai et al. 1977, 
Pikal et al. 1978 in Ahlneck and Zografi 1990). The increase in water content increases 
molecular mobility by reducing hydrogen bonding between adjoining molecules and 
decreases the value of Tg (Franks 1982; Levine and Slade 1987; Levine and Slade 1988; 
Slade and Levine 1988 in Ahlneck and Zografi 1990) (Fig. 8). This increased molecular 
mobility in metastable areas like amorphous regions can promote chemical degradation and 
solid-state phase changes, such as crystallization (Ahlneck and Zografi 1990). 
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Figure 8. Schematic representation on the effect of water on the Tg of the solute (Ahlneck 
and Zografi 1990, modified from the original) 
 
When producing crystalline material from solutions the fundamental driving force for 
crystallization is the chemical potential between the solution and the solid phase (Stieger and 
Liebenberg, 2012). This may also be expressed as supersaturation that is a solution with 
higher concentration of solids than in saturated solution at that defined temperature. 
Supersaturation is not a stable state and aims for equilibrium via free energy reduction which 
can be provided for example via crystallization. The crystallization from solution is currently 
not fully understood, especially the formation of nuclei (Chen J. et al. 2011). There are two 
suggested models: Classical nucleation model and Two-step nucleation model (Fig. 9). In the 
Classical model the molecules start building nuclei due to the fluctuations and this eventually 
may grow up to be a crystal, whereas in the Two-step model the molecules form larger 
clusters and later restructure to a more compact structure. The crystallization from solvent 
often leads to an API-solvate that is a metastable solid state of the solid molecules with 
solvent molecules in their crystal lattice (Stieger and Liebenberg, 2012). Solvates can 
sometimes be used for further development although this is often restricted by the possible 
existence of toxic solvent molecules in crystal lattice. The solvents may be removed from 
solvates although this may cause stability issues.  
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Figure 9.  The two nucleation models (Chen J. et al. 2011, modified from the original) 
 
The nucleation of molecules and crystal growth rate are dependent on the level of 
supersaturation (Stieger and Liebenberg, 2012). An increase in it leads to increased 
crystallization speed and decreased crystal size, though excessive increase may lead to 
amorphous material (Hancock and Zografi 1997). Some substances (like sucrose) can form 
supersaturated solutions of high stability that may postpone solidification (Elversson and 
Millqvist-Fureby 2005a). Supersaturation and therein crystallization may be achieved either 
by increasing the solute concentration or by decreasing the solute solubility or by combining 
both of the methods. Increase in solute concentration can be done by for example by 
evaporation of solvent and the decrease in solubility by cooling, addition of antisolvent, pH 
change or the addition of ions that participate in the precipitation of the solute. Interestingly, 
Kaialy and Nokhodchi (2012) reported that in antisolvent crystallization less saturated 
solutions produce higher fine fractions and less amorphicity in the final product. 
 
The solid state of the API is an important factor for inhalable small-sized powders due to the 
effects it has on stability and the performance of the processed API. This makes the decision 
of solid state a case specific challenge. The constant finding of new ways to produce new 
polymorphs (Stieger and Liebenberg, 2012) and the finding of new ways to stabilize 
amorphous structures increases the alternatives used for pharmaceutical production. 
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3.5 Hygroscopicity 
 
One of the duties of the upper airways is to heat and humidify the inhaled air to more than 
99% relative humidity and body temperature (Newman et al. 2009). In such conditions solid 
hygroscopic materials may quickly absorb water and grow in size whereas non-hygroscopic 
materials are mostly unaffected until a certain point is reached (Chew and Chan 2002, 
Columbano et al. 2002) (Fig. 10). The absorption of water on the surface of a particle may 
also enhance the adhesion force between the particles (Kawakami et al. 2010) and 
crystallization tendency (Ahmed et al. 1996).  
 
 
 
 
Figure 10. Schematic drawing of the effects of moisture content or relative humidity on the 
fine particle fraction of different types of powders. Line A represents a hygroscopic powder 
and line B represents a non-hygroscopic powder (Chew and Chan 2002, modified from the 
original).   
 
The water-induced particle growth might decrease exhalation and increase earlier lung 
deposition (Newman et al. 2009). The result is that the more hygroscopic substances 
deposition location and effect may be altered more. This would be especially critical for 
systemic delivery that is considered to be most efficient in the alveolar region (Chow et al. 
2007). It is also suggested that the smallest particle fractions would be the most sensitive 
particle fractions for moisture (Guenette et al. 2009; Crisp et al. 2010).  
 
3.6 Interparticulate interactions 
 
The performance of a DPI formulation is dependent on the interparticulate forces that should 
be optimized (Newman et al. 2009). They should be strong enough to promote stability 
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during storage and handling but weak enough to allow formulation de-aggregation and 
dispersion during inhalation. There are several forces that effect the interactions between 
particles:  
 
1. capillary forces  
2. electrostatic forces 
3. Van der Waals forces 
4. mechanical interlocking 
 
These forces are dependent on the environmental factors, material properties and processing 
conditions (Newman et al. 2009). The Van der Waals forces and mechanical interlocking are 
effective in short range contact points. The latter is dependent on the surface and particle 
shapes. Powder formulations are particularly affected by the capillary and electrostatic forces. 
Capillary forces are a result of the presence of water and can be minimized for example by 
individual blister packaging or with the help of desiccant. Electrostatic charging in powders is 
mostly caused via triboelectrification due to the contact between different surfaces and 
therein is involved nearly every process that involves powder handling (Karner and Urbanetz 
2011). It can be a nuisance causing material losses in packaging and processing but also a 
good instrument in modifying the characteristics of a powder. Mixing two oppositely charged 
powders, ordered mixtures can be created (Linsenbühler and Wirth 2005). The electrostatic 
charge of an aerosol can be modified by changing the API/excipient ratio (Karner and 
Urbanetz 2013), the size of particles (Murtomaa et al. 2004; Karner and Urbanetz 2013), 
presence of carrier fines (<40mm) and aerosolization airflow (Karner and Urbanetz 2013). 
 
The interparticulate forces can be divided in cohesive and adhesive forces (Newman et al. 
2009). Cohesive forces are attractive forces between similar molecules and adhesive forces 
between different molecules. The cohesion between particles in a powder mixture can be 
modified by changing the API/excipient ratio (Behara et al. 2011) or the size of particles 
(Guenette et al. 2009). This is supported by the results of Karner and Urbanetz (2013). 
Adhesive forces can be manipulated by changing the relative size of the interacting surfaces 
(Katainen et al. 2006; Thi et al. 2008) and the relative humidity (Zhu et al. 2008). For an 
interactive mixture formulation it was first noted that a minor increase in relative humidity 
decreases adhesive forces, increases FPF and ED. This was thought to be caused by 
dissipation of electric charges due to the increased moisture. An extensive increase in relative 
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humidity on the other hand starts to increase adhesive forces and decrease FPF and ED. This 
is thought to be caused by the increase of capillary forces via liquid bridges. 
 
3.7 Stability 
 
A formulation must be stable for the labeled shelf life and an inhalation product is no 
exception (Newman et al. 2009). The stability of the produced formulation must be adequate 
in manufacturing to sustain possible further processing, storing and packaging. In an inhalator 
the formulation must sustain handling, usage and environmental factors like temperature and 
humidity (Newman et al. 2009). Finally in the human respiratory tract the formulation must 
sustain that environment adequately to allow the designed drug dosing (Bechtold-Peters et al. 
2007). 
 
DPI formulation is considered to be reasonably stable when compared to liquid formulations 
and it has no requirements for sterile manufacturing (Newman et al. 2009). Therefore it is 
even used as a way to stabilize macromolecules (Bechtold-Peters et al. 2007; Newman et al. 
2009) and minimize microbiological contaminations (Bechtold-Peters et al. 2007). The 
stability also presents challenges as the drug and carrier agglomerates separation in carrier 
formulations is partly dependent on the inspiratory effort from the patient (Newman et al. 
2009). The intact remaining part of the agglomerates deposits in the upper airways and does 
not necessarily provide the wanted pharmacological effect. This and the possible moisture 
sensitivity of the powder are among the greatest challenges with DPI formulation stability. 
While water alone can promote chemical and physical reactivity (Ahlneck and Zografi 1990), 
this is increased even further when combined with temperature increase (Burnett et al. 2004). 
Promoted chemical and physical reactivity may cause solid state transitions like 
crystallization. Different storage temperatures and humidities can facilitate growth of 
different polymorphs (Bianco et al. 2012).  
 
 
4 SPRAY DRYING 
 
A basic spray dryer composition is illustrated in Figure 11 (Büchi 2012). The spray dryer is 
used to process food, biochemical compounds and pharmaceutical substances (Masters 2002). 
The reason for such popularity is its relative simplicity, availability, applicability and ease of 
operation. In the field of inhalation particle processing however, it is a rather new technology. 
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This is because of the relative small particle size and size distribution that require 
considerable amount of process optimization.  
 
 
 
Figure 11. Technical drawing of the B-290 spray dryer. (www.buchi.comTMS, modified 
from the original) The prepared mixture to be spray dried composes the feedstock (1.). From 
the feedstock the mixture is pumped to the nozzle (2.), from where it is sprayed to drying 
chamber (3.). The final product is collected mainly in the cyclone (4.) and partly in the filter 
(5.) 
 
The spray drying cycle can be open, closed or semi-closed (Masters 2002). Open cycle means 
that the drying medium is air that is released to atmosphere after passing through the process. 
The closed cycle system is used to prevent fire and explosion risks (e.g. flammable solvent or 
solute), environmental and working area toxicity (toxic solvent or solute) or to prevent 
contact with oxygen (oxidation). Closed cycle uses some inert gas (e.g. nitrogen) that is 
recycled during the process. A semi-closed cycle is used to partially minimize either fire risk 
or exhaust air toxicity. This is achieved by lowering the oxygen concentration of the drying 
medium or in the latter case by minimizing the exhaust air by recycling. Spray drying process 
can also meet aseptic/hygienic processing conditions if needed. 
 
To produce crystalline particles of inhalable size in a single process would be beneficial for 
its stability (Stieger and Liebenberg, 2012) and rapidity (Masters 2002). Spray drying is a 
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rather quick method and is known to produce particles of inhalable size, though the quality is 
often amorphous (Masters 2002). The reasons for amorphous product are said to be the very 
fast precipitation of the material and the lack of an isolation time. To produce more 
crystalline material one has to change the parameters used (Chiou et al. 2008). In a spray 
dryer both the formulation parameters and the process parameters contribute to the quality of 
the product (Chan and Chew 2003). In studies conducted by Tajber et al. (2009b) even 7-fold 
increases in respirable fraction (< 6.4µm) have been noted due to the process parameter 
optimization. For a new processed substance it may be challenging to utilize any former 
process parameter data and therefore experimental work is unavoidable (Gallo et al. 2011). 
 
4.1 Mixture composition 
 
Virtually any pumpable mixture can be used for spray drying (Masters 2002). This limits the 
mixture to be composed of at least one liquid component mixed with other liquid or solid 
components. The liquid component is usually water but non-aqueous volatiles, like organic 
solvents, can be used (Masters 2002). In some cases the feed can also be molten. The 
important parameters in the mixture are the number and amount of components, their 
contribution to the mixture (Bosquillon et al. 2001; Traini et al. 2012) and the solubility of 
the solid components in the liquid mixture (Gilani et al. 2004) as the behavior of solution and 
suspension differs in spray drying (Masters 2002). 
 
 The solid concentration in the mixture is a significant parameter (Cheow et al. 2010). An 
increase in it has been noted to increase several factors including: particle size (Elversson et 
al. 2003; Corrigan et al. 2004; Mosen et al. 2004; Elversson and Millqvist-Fureby 2005a; 
Maury et al. 2005; Sansone et al. 2009; Amaro et al. 2011; Gallo et al. 2011; Buchi process 
parameters guide 2012), yield, width of the particle size distribution (Corrigan et al. 2004), 
density (Elversson et al. 2003), surface roughness (Gad et al. 2012) and the thermal 
efficiency of the spray dryer (Masters 2002). Decreases have been noted in the humidity of 
the final product (Maury et al. 2005; Amaro et al. 2011; Buchi process parameters guide 
2012). Concentration is a major factor for crystallization (Stieger and Liebenberg, 2012) 
although the effect of concentration on solid state has been noted to depend on the type of the 
spray-drying cycle (Bianco et al. 2012). It is also claimed that high concentrations might slow 
down crystallization due to the lower initial moisture and higher heat capacity (Chiou and 
Langrish 2008). Lower moisture would not decrease the Tg effectively and higher heat 
capacity would slow the heating of droplets to more crystallization favoring temperatures. 
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The lower solubility of the solute is also said to increase particle size (Elversson and 
Millqvist-Fureby 2005a). The pH of the feed is found to be a significant factor when the feed 
has pH specific components and it has effects on particle size distribution of the product 
(Cheow et al. 2010). 
 
The type of feed used dictates the performance in the spray dryer (Masters 2002). Generally 
droplets containing suspended solids tend to dry faster than solution droplets containing 
solids or emulsion droplets. This is caused by the differences in moisture migration. 
Interestingly, yield is noted to improve when using solutions instead of suspensions with the 
same amount of solids though the change in solvent ratio might have an effect as well 
(Sansone et al. 2009). The use of a suspension may facilitate nanoparticle production in spray 
drying (Bhavna et al. 2009). An increase in nanoparticle size and suspension concentration 
was noted to increase the size of produced nanoparticle polymer composites and an increase 
in molecular weight of the polymer seems to increase mean particle size (Beck-Broichsitter et 
al. 2012). An increase in concentration of suspension was also noted to affect the shape of 
particles and decrease the uniformity of the particle size distribution (Cheow et al. 2010). The 
addition of solids over the solubility limit of the solution does not linearly change the solid 
state of the final product (Chidavaenzi et al. 1997). 
 
The type and the amount of the excipients seem to affect greatly on the quality and 
performance of the formulation (Bosquillon et al. 2001) especially on shape of the particles 
(Corrigan et al. 2004). An addition of polymers was noted to increase surface roughness 
(Kawakami et al. 2010) whereas an increase in colloidal silicon dioxide was found increasing 
flowability properties, compactability and stability (Gallo et al. 2011). When spray drying 
protein products, the density of particle was noted to increase (Maltesen et al. 2008) and 
particle corrugation decrease when protein concentration is increased (Adi et al. 2008). The 
overall effect of the addition of proteins and lipids in a formulation is a decrease in density 
whereas the increase in sugar concentration led to an increase in bulk density (Bosquillon et 
al. 2001). 
 
The performance of lactose in an Andersen Cascade Impactor (ACI) was considered better 
than that of mannitol and trehalose when combined with dipalmitoyl phoshatidylcholine 
(DPPC) and was further improved with the addition of albumin. Many carbohydrates like 
isomalt, lactitol, maltitol, xylitol and sorbitol may be challenging to process with spray dryer 
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(Gonissen et al. 2007). With the Gordon-Taylor (Gordon and Taylor 1952 in Corrigan et al. 
2004) equation it seems possible to predict the stability and formation probability of an 
amorphous structure in composites (Corrigan et al. 2004). The Tg of the composite should be 
high enough to yield Kauzmann temperature higher than storage temperature in order to be 
stable. A crystalline excipient has been noted to produce porous particles whereas amorphous 
excipients produce hollow particles (Elversson and Millqvist-Fureby 2005a). The addition of 
pore formers, such as ammonium carbonate is sometimes preferred to produce porous 
particles (Healy et al. 2008, Nolan et al. 2009). Leucine can be used as an additive to lower 
cohesiveness and thereby increase the yield and aerosol performance (Boraey et al. 2012). 
 
Spray drying can be used to crystallize substances in situ from solvent mixtures (Mezzena et 
al. 2009; Bianco et al. 2012). The level of crystallization in water soluble material was 
increased when the water concentration was decreased (Harjunen et al. 2002a; Gilani et al. 
2005; Bianco et al. 2012) and when the concentration of solid material was increased 
(Chidavaenzi et al. 1997). Ethanol soluble materials seem to show similar trend as less 
crystalline materials are produced as the ethanol concentration increases though there are 
contradictory results (Gad et al. 2012). The use of co-solvent system (Harjunen et al. 2002a; 
Gilani et al. 2005; Bianco et al. 2012; Gad et al. 2012), adding excipients (Carr et al. 2011) 
and combinations thereof have been used to produce more crystalline solution. Crystallinity 
can also be lowered by adding different substances to the mixture (Traini et al. 2012). A more 
crystalline product can also be obtained by spray drying precrystallized mixtures (Rasenack 
et al. 2002). 
 
The use of organic solvents instead of water may decrease energy consumption provided that 
the boiling point of the used organic solvent is lower than that of water (Buchi process 
parameters guide 2012) and may facilitate dissolution of less water soluble components 
(Muttil et al. 2007; Boraey et al. 2012). Organic solvents that reduce surface tension may 
cause reduction in particle size (Buchi process parameters guide 2012; Bürki et al. 2011) and 
may increase FPF (Sansone et al. 2009). As the ethanol concentration is increased there is no 
noted further change in particle size but the density of powder will increase (Bosquillon et al. 
2001) and particles seemed to be more spherical (Gad et al. 2012). The effect of the 
ethanol/water ratio on particle shape seems to be dependent on the solubility of substances in 
different tested solvent mixtures. The roundness of the particles produced by Harjunen et al. 
(2002a) increased with water soluble substance when moved towards more water abundant 
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solutions and Gad et al. (2012) produced rounder particles with ethanol soluble substance 
from ethanol abundant solutions. The increased solubility may facilitate solid state change of 
a particle but not always, since Gad et al. (2012) produced crystalline quality in all 
experiments. Apparently also the particle size change effected by ethanol concentration is 
dependent on various things as Sansone et al. (2009) noticed. Increased ethanol 
concentrations with ethanol soluble substance produce smaller particles. The use of organic 
solvent and water mixtures can be beneficial especially when the aim is to produce small 
porous particles as it is claimed that the mixing ratio may adjust the pores (Nolan et al. 2009). 
A mixture of water and methanol is preferred over a mixture of ethanol and water due to the 
narrower size distribution and more uniform shape produced (Healy et al. 2008; Nolan et al. 
2009) although other solvent mixtures can be used as well (Nolan et al. 2011). 
 
4.2 Feeding phase 
 
In the feeding phase the adjustable properties are: possible pretreatments before pumping the 
prepared liquid feedstock to the nozzle, pump rate and physical variables like hose length and 
material. To transfer the feed from feedstock to the nozzle a transfer pump, such as rotary, 
centrifugal (Masters 2002) and peristaltic, can be used. The pumping is generally not that 
demanding in spray drying unless very high pressure nozzle atomization is used. The feed 
pretreatment can for example be mixing (Masters 2002; Stieger and Liebenberg 2012), 
heating (Masters 2002), adding of gas, concentrating of feed, filtering or mixture thereof. 
 
Mixing is introduced to maintain homogeneity (Galloe et al. 2011; Stieger and Liebenberg 
2012), but it also has some complex effects on nucleation and crystal growth in the mixture 
(Stieger and Liebenberg 2012). The mixing of a constant supersaturated solution with no 
crystals yet present decreases the induction time (time when crystals first appear) with the 
increase of stirring speed till critical speed is reached. This is due to the active creation of 
secondary nuclei by crystal impacting on other crystals, vessel or impeller. The increased 
creation of nuclei also leads to decrease in the ultimate crystal size of the product and 
apparently can affect the chiral symmetry of the product. The crystal growth is also stirring 
intensity dependently limited.  
 
Heating is added to reduce feed viscosity and to prevent feed crystallization (Masters 2002) 
but it also effects the saturation (Stieger and Liebenberg 2012). Lower viscosity in feed is 
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sometimes desired as it tends to produce homogenous sprays and smaller particle size 
(Masters 2002). The effect of heat on crystallization tendency might be related to the 
materials used as Alves and Santana (2004) found that an increase in temperature might 
increase crystallization propensity. Gas addition can be included to decrease the bulk density 
and alter the morphology (Masters 2002; Steckel and Brandes 2004). The feed concentrating 
is done to increase density (Masters 2002) and combining it with an increase in feed rate is 
said to increase crystallinity (Alves and Santana 2004). 
 
An increase in the feed rate increases the amount of solvent to be evaporated and material to 
be dried. It also increases the spray angle, bulk density of the product (Masters 2002), the 
droplet size of the spray (Maury et al. 2005; Buchi process parameters guide 2012), particle 
size, humidity of the final product (Masters 2002; Maury et al. 2005; Tajber et al. 2009b; 
Gallo et al. 2011; Buchi process parameters guide 2012; Shi et al. 2012), but decreases the 
outlet temperature (Maury et al. 2005; Maltesen et al. 2008; Amaro et al. 2011; Buchi 
process parameters guide 2012).  An increase in flow rate has also been noted to increase FPF 
of the powder (Boraey et al. 2012). 
 
At higher liquid feed rates the atomization becomes incomplete, droplet size distribution 
becomes wide (Masters 2002), drying chamber becomes wetted (Cheow et al. 2010) and 
yield drops (Tajber et al. 2009b; Cheow et al. 2010; Gallo et al. 2011). Coupling an increase 
in feed rate with an increase in atomizing gas flow is suggested to avoid further challenges 
(Cheow et al. 2010; Gallo et al. 2011) and to increase yield (Tajber et al. 2009b). The 
increase in drying time due to the increased moisture (Maltesen et al. 2008) could possibly 
prolong crystallization time in spray drying (Chan and Chew 2003) and increase the 
formation of hydrates (Chidavaenzi et al. 1997). The dependency of crystallinity on feed rate 
is claimed insignificant by Das et al. (2010), although opposing results are also available 
(Islam and Langrish 2009). There are studies where the effects of feed rate are found not to 
be significant for product characteristics (Bosquillon et al. 2001; Maltesen et al. 2008).  
 
The physical attributes like hose material and length may contribute to the quality if they 
subject the liquid mixture to energy changes (light, temperature, radiation) or unsuitable 
materials. Temperature oscillation is known to promote crystallization (Stieger and 
Liebenberg, 2012). Crystallization can also be promoted in capillary tubes that affect 
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evaporation, turbulence and convection, such as feeding hoses. These types of factors are 
considered meaningful mainly for supersaturated solutions. 
 
4.3 Spraying phase 
 
In the spray phase the produced feedstock is broken up into a spray of spherical droplets sized 
5-600 µm (i.e. atomization) by using different techniques (Masters 2002). The size of the 
droplets is not the same as particle size but they are closely related. This is due to the droplet 
drying. Spray is produced due to the frictional forces created between the atomizing gas and 
the liquid feed. This process can be divided in two phases: tearing of liquid into thin 
filaments and further disintegration of droplets (Hede et al. 2008). Thereafter the produced 
droplet leaves the atomizer and gets into complex interaction with the surrounding gas, with 
other droplets in the spray cloud and with the unknown stresses within the droplet. There are 
different theories and neither of them is considered accurate due to the complexity of the 
process. The main adjustable parameters in spraying phase are: the nozzle, the liquid feed and 
the spraying gas. 
 
The properties of the liquid feed that affect the performance of the pneumatic nozzle are 
surface tension, density and viscosity of the liquid (Masters 2002, Hede et al. 2008) of which 
the viscosity is said to be the most important parameter in controlling the mean droplet size 
(Hede et al. 2008). The surface tension and viscosity are considered to be opposing forces for 
the disintegration of the liquid (Masters 2002) whereas the effects of density are rather 
complex (Hede et al. 2008). An increase in feed rate, viscosity (Masters 2002; Gallo et al. 
2011) and surface tension tend to produce larger droplets (Gallo et al. 2011). The dependency 
of droplet and particle size was verified by Kawakami et al. (2010). Larger droplets are more 
favorable for crystallization because of the longer lifetime of the droplets and hence higher 
chances of crystallization (Elversson and Millqvist-Fureby 2005a). 
 
Pneumatic nozzle turn-down ratio and capacity are somewhat more limited than for example 
in the rotary atomizer and that is why duplication of the nozzles is used to increase the feed 
rate. The advantages of pneumatic nozzle are the high homogeneous spray quality and small 
mean droplet size and considerably low operating pressures (Masters 2002). The mean 
droplet size can reach 2-5 µm with small nozzle bodies, low feed rates and low viscosity 
feedstocks.  The operational pressures of pneumatic nozzles are typically below 7 bars 
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whereas in pressure atomization the pressures used can be more than 500 bars. There are four 
different types of pneumatic nozzles: internal mixing two fluid nozzle, external mixing two 
fluid nozzle, combined internal-external mixing three fluid nozzle and pneumatic cup 
atomizer nozzle. 
 
 
Figure 12. Examples of external (left) and internal (right) mixing nozzle designs (Salman et 
al. 2007 in Hede et al. 2008, modified from the original) 
 
The internal mixing nozzle contacts the air and liquid within the nozzle head whereas the 
external type contacts them outside the nozzle head (Masters 2002) (Fig. 12).  Due to these 
structural differences the internal mixing achieves higher energy transfer and the external 
mixing provides greater control on the gas and the liquid streams. The combined internal-
external mixing nozzle combines these two benefits and is therefore often used for difficult 
high viscosity liquids and also to produce aerosol size range products. The pneumatic cup 
atomizer contacts gas and liquid at the rim of a rotating nozzle head. It is used to produce fine 
sprays from low and medium viscosity feeds. There are also many variations of the four 
nozzle types (Hino et al. 2000; Ozeki et al. 2006). The most commonly used design is the 
external mixing two-fluid type of nozzle (Hede et al. 2008) which was also used in this study. 
In this type of a nozzle the atomizing gas and the liquid feed go separate ways to the nozzle 
and collide just outside the nozzle tip to produce a spray cone (Masters 1991). The colliding 
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outside the nozzle tip does apparently not mix the liquid feed significantly (Janssens et al. 
2009) unless two different feed passages are used (Ozeki et al. 2006). Spray cones are 
dictated by the properties of the liquid, the nozzle design and operating parameters and affect 
the product quality (Masters 2002).   
 
The nozzle orifice in pneumatic nozzles is larger than in a pressure nozzle which is an 
advantage due to the smaller likelihood for nozzle clogging (Masters 2002). There are various 
designs for spray orifice shape that produce different kinds of spray cones such as a full cone, 
a hollow cone and a flat cone (Hede et al. 2008). An increase in the nozzle orifice size has 
been noted to increase the crystallinity of the product (Alves and Santana 2004), an increase 
in the particle size (Elversson et al. 2003) and an increase in wall deposition due to the 
increase in spray cone breadth. The use of suspensions with high solid content may subject it 
to a milling effect in the spray nozzle (Chidavaenzi et al. 1997) and this milling effect could 
increase the apparent solubility that could potentially increase the amorphous content 
(Buckton and Beezer 1992 in Chidavaenzi et al. 1997). The solubility of the solids in the 
solution would be further influenced by the temperature of the nozzle as it passes by. To 
minimize this influence of temperature some nozzle models can be cooled with a water 
circulation system. 
 
The quality and amount of the spraying gas has effects on the product quality. An increase in 
the spraying gas density while maintaining the velocity increases the dynamic force of the gas 
and results in a decrease in mean droplet size (Masters 1991). The use of different spraying 
gases may affect the morphology of the particles (Islam and Langrish 2010b). The amount of 
sprayed gas can be regulated by adjusting the pressurized gas flow rate by a control valve 
(Masters 2002). Therein the spraying gas amount can be adjusted by adjusting the pressure or 
the airflow.  The spraying gas pressure is said to have a minor impact on the product quality 
(Bosquillon et al. 2001). This can be considered as an interesting result because the effect of 
the gas flow was considered as the factor with the most significant effect on particle size by 
Maltesen et al. (2008). An increase in gas flow increases yield (Goula et al. 2005; Amaro et 
al. 2011), decreases geometric particle size (Juslin et al. 1995; Elversson et al. 2003; Goula et 
al. 2005; Cheow et al. 2010; Amaro et al. 2011; Gallo et al. 2011) and specific surface area 
(SSA) (Amaro et al. 2011) but is said to be insignificant in relation to the level of crystallinity 
in the product (Das et al. 2010). The air-to-liquid mass flow rate (ALR) is found to be more 
useful than the gas flow itself (Hede et al. 2008; Cheow et al. 2010; Gallo et al. 2011). 
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4.4 Drying phase 
 
The produced spray of spherical droplets is contacted with gas involving flow and mixing. 
This causes the droplets to dry into individual particles while moving in a gaseous drying 
medium (Masters 2002). The heat of evaporation for a droplet drying is supplied by the heat 
of the drying medium, which is usually air or an inert gas like nitrogen (Maltesen et al. 2008; 
Masters 2002). The details in the drying phase are considered rather challenging to describe 
due to the experimental challenges with nucleation and crystal growth and theoretical 
challenges with material properties in supersaturated solutions (Vehring et al. 2007). 
 
Two types of moisture can be found in the liquid feed: bound and unbound moisture (Masters 
2002). Bound moisture can be found from capillaries in solids, adsorbed in solid surfaces, 
from cells, fiber walls or in crystals as hydrate. The rest of the moisture in a hygroscopic 
material is unbound moisture. In a non-hygroscopic feed all moisture is unbound. The 
amount and quality of the moisture in a material is a parameter that defines the drying 
characteristics for a droplet. The drying can be divided into two steps: constant rate drying 
from the surface and drying after the surface saturation can no longer be maintained. In the 
first drying step the temperature remains constant due to the evaporation and product is not 
subjected to any rapid temperature increase. In the second step the particle temperature could 
rise, but it is subjected to lower temperatures. The rate of the water evaporation is found to 
affect the surface morphology greatly (Shi et al. 2012). 
 
The drying process of solution and emulsion differ from the suspension (Fig. 13). A 
suspension droplet, when contacted with drying air, begins to dry more or less at a constant 
rate (Masters 2002). This brings the insoluble particles closer to each other. The next drying 
phase begins when the surface wetness can no longer be maintained due to the insufficient 
capillary mechanisms. This is the beginning of the funicular phase where the liquid is in 
pores filled with capillary flow. The final state of drying starts when capillary flow ceases 
and vapour diffusion starts to dominate. This pendular state continues until the particle has 
dried.  The drying of a solution or emulsion droplet starts also more or less at a constant rate 
when contacted with drying air. In this period the temperature of the droplet can be equated 
to that of the saturated solution but the surface concentration can be less than equal with 
saturated solution. This period of drying ceases when the droplet moisture content falls to a 
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critical value and a solid phase forming at the droplet surface is detectable. The increased 
solidification decreases the moisture migration from the core and heat transfer starts to 
exceed mass transfer. This causes the particle to heat up and if the surrounding air 
temperature is adequately high (above the boiling point of the droplet solution) the liquid 
inside the droplet starts to form vapour. The vapours will escape the particle via the surface 
and may affect the morphology depending on the nature of the solid layer on the droplet 
surface. If the solid layer is easily penetrated e.g. a porous surface, the morphology is less 
affected. On the other hand, if the surface is non-porous `plastic´ (impervious) film, the 
evaporation time for removal of complete volatiles is greatly extended and the droplet may be 
subjected to significant morphology modifications, such as expanding, collapse, rupture or 
even disintegration. The thickness of the solid layer increases as the solid concentration of the 
feed increases (Elversson et al. 2003; Fu et al. 2012). In a co-current mode spray drying the 
droplets does not usually reach boiling point level moistures. Irrespectively of the conditions 
used the volatiles movement within a spray dried droplet is first controlled by liquid 
diffusional mechanisms and then by vapour diffusional mechanisms. 
 
 
Figure 13. The drying phases of suspension (A) and solution/emulsion (B) (based on Masters 
2002).  
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During spray drying process the initially spherical droplets undergo both size and shape 
changes (Masters 2002). Some may expand, others collapse, form blow holes, agglomerate or 
disintegrate on mechanical handling. The resulting material will be powder, granules or 
agglomerates depending upon the physical and chemical properties of the feed, the dryer 
design and parameters used. It may also have a wide degree of different particle shapes 
because of the individual conditions for each particle. The rapid solidification in spray drying 
may cause phase separation or crystallization that can be harmful for the protein structure 
(Ståhl et al. 2002). There apparently is a critical crystallization period in the drying phase, 
which dependent on moisture and temperature (Woo et al. 2012). Modifying this period 
would possibly affect the crystallinity of the product. This possibility for crystallization is 
criticized by Chidavaenzi et al. (1997) due to the lack of time for crystallization. 
 
An increase in the inlet temperature in spray drying was found to increase density 
(Bosquillon et al. 2001), the level of crystallization (Chiou et al. 2008; Islam and Langrish 
2009; Mezzena et al. 2009; Islam and Langrish 2010a; Fu et al. 2012), yield (Goula and 
Adamopoulos 2005), outlet temperature (Gallo et al. 2011), evaporation rate (Shi et al. 2012), 
variation of size (Fang et al. 2012), particle size (Fu et al. 2013) and produce particles with 
increased surface roughness (Maas et al. 2011; Fang et al. 2012). The particle size was found 
to be relatively unaffected by temperature (Maas et al. 2011). Combining high inlet 
temperatures with low feed rates are found to produce smaller, denser and more homogenous 
particles (Cabral-Marques and Almeida 2009).  
 
 The effect of inlet temperature is claimed to be related to the glass transition temperature 
(Tg) of the material (Islam and Langrish 2009) (Fig. 14). It was observed that with low 
temperatures the yield was decent, when the presence of moisture decreased the Tg (Islam and 
Langrish 2009, Shi et al. 2012). When the inlet temperature was increased, the particle 
temperature Tp was increased, the moisture content decreased and allowed the Tg to increase 
resulting in a decrease in yield due to ´The Stickiness Barrier´ that was reached. In this 
temperature area an amorphous product is produced that behaves in a sticky manner in a 
spray dryer. However, increasing the temperature even further results in an increase in 
particle temperature Tp, but as the materials Tg is reached the difference in (Tp -Tg) increases 
resulting increased yield and crystallinity. This is further confirmed by Islam et al. (2010) by 
insulating the system to produce higher Tp and by increasing the humidity of the drying gas to 
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lower the Tg. The material produced with this installation was significantly crystalline. The 
increase in crystallinity is postulated to increase in larger scale equipments that have longer 
residence times and hence more time for crystallization (Islam and Langrish 2009). This 
hypothesis was later challenged by Das et al. (2010) as they noted that the highest 
temperatures do not necessarily produce the most crystalline products in a pilot-scale spray 
dryer. The reason was thought to be caused by the slower drying of larger particles that did 
not produce adequate difference in (Tp -Tg) in these temperatures and timescales.  
 
 
Figure 14. The concept of stickiness barrier represented in schematic picture (Islam and 
Langrish 2009, modified from the original) 
 
Although thermal stress can be an issue for thermolabile substances such as proteins (Maa et 
al. 1998; Millqvist-Fureby et al. 1999; Ståhl et al. 2002) and certain salts (Gad et al. 2012) it 
is considered as a minor problem in spray drying. The outlet temperature is considered as a 
limiting factor by Ståhl et al. (2002). The droplets are only briefly exposed to the inlet 
temperature (Masters 1991) and the product temperature will remain considerably lower than 
the inlet temperature due to the cooling by latent heat vaporization (Chan and Chew 2003). 
The temperature can be also reduced by lowering the feed temperature compared to the 
drying gas temperature (so called “wet bulb” effect).  
 
The drying gas quality, content and flow rate have significant effects on the drying 
performance of spray dryer. Most often the drying medium is atmospheric air, but nitrogen 
and carbon dioxide have been widely used as well. The used gas type may have an effect on 
the solid state properties (Islam and Langrish 2010b; Bianco et al. 2012) and morphology of 
the spray dried powders (Nolan et al. 2009; Islam and Langrish 2010b). This may be partly 
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due to the different humidities present in the gases and partly due to the different physical 
properties of the gases. In a closed loop system there is also a theoretical possibility that the 
recirculated gas can remain contaminated despite the condensation phase and affect the 
product properties (Bianco et al. 2012). The used drying gas can be humidified (Islam et al. 
2010) or dried (Masters 2002; Goula and Adamopoulos 2005; Maltesen et al. 2008) before 
contacting with the liquid feed. The lower humidity of the drying air combined with lower 
inlet temperature can improve product yield (Goula and Adamopoulos 2005). 
 
The drying chamber is usually a cone-shaped structure made of stainless steel (glass in 
laboratory) (Weiler et al. 2010) varying in size and form according to the flow mode and 
operation parameters used (Masters 2002). Modifying the drying chamber (Maury et al. 
2005) or adding insulation (Masters 2002; Islam and Langrish 2010a; Islam et al. 2010) can 
increase the thermal efficiency of the system and crystallization (Islam and Langrish 2010a) 
via increase in outlet temperature. Modifying the drying chamber dimensions is also a factor 
that affects the residence time for the particle in the system (Chan and Chew 2003). An 
increase in the dimensions is postulated to increase the level of crystallization (Islam and 
Langrish 2010a). 
 
The gas and droplet flow inside the drying chamber can either be to the same direction (co-
current flow mode), in the opposite direction (counter-current flow mode) or a mixture 
thereof (Masters 2002). The co-current flow mode is a rapid process and suitable for sensitive 
products because it does not subject the product to any rapid temperature increases. The 
counter-current flow mode instead, subjects the driest powder to the most intense heat and 
also to the newly formed droplets. The latter mode is suited for coarse droplet size nozzle 
atomization to allow larger particles to dry more efficiently. Mixed-flow mode can be used to 
produce small particles but it subjects the particles to higher temperatures during the process. 
Decreasing the temperature gradient around the atomizer will decrease the evaporation rate 
(Ståhl et al. 2002). This will lead to more uniform size and shape of the particles. This will 
also increase particle density and roundness. 
 
The spray drying can also be done in lower or higher pressures than atmospheric pressure 
(Masters 2002). Lower pressure conditions increase the rate of solvent evaporation (Masters 
2002; Stieger and Liebenberg, 2012) and high pressure has been used only recently to 
encourage denser packing structure but may also impede crystallization (Masters 2002). 
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Pressure change also changes the solubility of a given polymorph or solvate possibly even at 
the expense of another (Stieger and Liebenberg, 2012). This might encourage 
recrystallization on certain occasions. There is also some evidence that pressure can induce 
changes in the solid form. Pressure can also induce structural changes in solid-state molecular 
crystals, though this is thought to be only a partial change. It was found that lowering the 
pressure in spray drying process increases the level of crystallinity (Eslamian and Ashgriz 
2006). The usages of systems with other than atmospheric pressure are in most cases found 
technically and operationally challenging (Masters 2002). 
 
4.5 Recovering phase 
 
After the drying chamber the discharge of the particles takes place at the base of the drying 
chamber and in a dry collection equipment e.g. cyclone, bag filter or electrostatic precipitator 
(Masters 2002). It can also be recovered wet in wet scrubbers and wet cyclones. The product, 
when recovered dry, can be mixed with the main powder fraction leaving the base of the 
drying chamber or reprocessed in the feed formulation or transported for further processing. 
Further processing can be a cooler, an agglomerator or a granulator. The wet recovery 
systems are considered to be insufficiently hygienic for most dairy products, food products 
and pharmaceuticals if the solids need to be recovered as powders.  
 
The cyclone is a dry centrifugal particle separator used in conjunction with a spray drying 
chamber (Masters 2002). In a cyclone the gas and particles form a vortex where the particles 
are subjected to centrifugal forces and drag forces of the air. Powders and air swirl down the 
cyclone, where the powder leaves the cyclone and deposit into the product vessel while the 
air spirals upwards along the axis of the cyclone exiting from the top (Fig. 15). The 
deposition place for a particle is dependent on the drying characteristics of the product, 
structure of the drying chamber, speed of spraying and drying gases. Cyclones are low in 
costs and easy for maintenance, though they are not 100% efficient and therefore require 
some additional secondary collector stage. The efficiency of a standard cyclone (height 0.340 
m and diameter 0.135 m) is said to be poor for smaller particle sizes (Mosén et al. 2004; 
Maltesen et al. 2008). The cut-off diameter (less than 50% of particles captured) for this 
cyclone is considered to be 2 µm (Mosén et al. 2004). Changing the drying gas velocity and 
cyclone diameter might increase efficiency. A smaller cyclone is found to increase yield and 
preserve enzymatic activity better than a larger one (Bögelein and Lee 2010). This is thought 
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to be because of the better retention and separation of FPF in the cyclone. A cyclone can 
operate under pressure or in vacuum (Masters 2002). An increase in aspirator value can 
increase the efficiency in cyclones particle separation (Buchi process parameters guide 2012) 
and a decrease in product cohesiveness (Boraey et al. 2012) 
 
 
Figure 15. Cyclone separation principle (Masters 2002, modified from the original) 
 
The secondary collector stage collects the finest fraction simultaneously purifying the 
exhausting gas with dry or wet based mechanism (Masters 2002). A bag filter is one of the 
most commonly used devices for secondary collector stage and it may be used occasionally 
even to replace the cyclone. It is considered as virtually 100% efficient. An electrostatic 
precipitator is sometimes used to replace a cyclone and bag filter combination, although it is 
rather expensive. It is advisable to consider the nature of the product while choosing the 
collection equipments, because it may subject the particles to some mechanical forces and 
alter the product size and shape. Cyclones, for example, tend to increase the fine particle size 
especially for fragile particles. 
 
The amount of yield is a result of many variables and their interactions. Feed concentration 
(Maltesen et al. 2008; Amaro et al. 2011), feed rate (Amaro et al. 2011), and inlet 
temperature are found to be parameters that have positive effect on the yield when increased. 
Small particle size is found to decrease yield (Mosén et al. 2004; Maltesen et al. 2008). Spray 
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gas flow had a negative correlation with yield when increased. Combining the increase of 
feed concentration with either spray gas flow decrease or feed concentration increase resulted 
in significant effects.  
 
4.6 The spray drying parameters 
 
The spray drying parameters from the literature are summarized and explained in Table 1.  As can be 
observed the effect of many parameters seem to be quite varying. This indicates possibly the 
complexity of the spray drying process, the dependency of parameters from the quality of the 
substance and also the used range of the parameters. For each row two references are specified. 
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5 ANNEALING 
 
The inherent instability of many water soluble amorphous substances results possibly in 
uncontrolled crystallization when exposed to high humidities (Elamin et al. 1995) and 
inadequately high temperatures (Burnett et al. 2004). To address this instability a process that 
will increase the stability is necessarily. One way to solve this problem is to expose the 
instable amorphous material to conditions that would allow the material to crystallize in a 
controlled environment and in short time frames (Brodka-Pfeiffer et al. 2003). This process 
where temperature and humidity are controlled is referred as annealing but is known also as 
conditioning. 
 
Model substance will be annealed in order to study their solid state transformation tendencies 
and therein their storage stabilities (Brodka-Pfeiffer et al. 2003). This process is done to the 
raw materials as well as for the spray dried products. The annealing of the raw materials was 
designed to address the concern that the micronized raw material might not be totally 
crystalline (Fix and Steffens 2004; Grisedale et al. 2011). An increase in amorphous 
character has been observed when micronizing material with ball milling (Willart et al. 
2004). 
 
The annealing solvents used were ethanol and water. They acted as plastizers to promote the 
molecular movement needed for solid state transformations (Ahlneck and Zografi 1990). A 
more water soluble substance would be annealed with water vapour (Ali et al 2012) although 
ethanol vapour could possibly have been equally adequate (Trofast et al. 1992). A less water 
soluble substance would be annealed with ethanol vapour which could facilitate its 
crystallization better than water or water-ethanol solutions (Ahmed et al. 1996). The 
annealing values chosen (temperature and solvent vapour activity) should exceed certain 
levels in order for the process to happen (Brodka-Pfeiffer et al. 2003; Adilovic 2012; 
Grisedale et al. 2012). It is also advisable to minimize locally progressive crystallization of 
powder (Buckton and Darcy 1995) and add a purging gas to facilitate mixing (Trofast et al. 
1992). Further optimization is suggested to minimize unwanted particle growth which 
seemed to increase with the used relative humidity (Brodka-Pfeiffer et al. 2003).  
 
The crude powder annealing method is conducted by subjecting the sample for the chosen 
solvent vapours in a tightly sealed box. This box would be a two storied transparent box kept 
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in room temperature (23oC) with a sealable door. In the water vapour annealing system a salt 
solution of NaBr in water is put in petri dish on the lower floor to provide the desired relative 
humidity. In the ethanol vapour annealing system the boxes have ethanol activities that were 
also created on a petri dish with the help of salt solutions. The annealed substance would be 
located on the higher floor spread into a petri dish or applied on an XRPD plate. After the 
crude tests, a more elaborate small scale flow-annealing system (Fluxus, AstraZeneca, 
Sweden) is used to anneal the more water soluble substance. This equipment is developed by 
AstraZeneca (Trofast et al., 1992) and is described in an MSc thesis by Adilovic (2012). 
 
 
6 AIMS OF THE STUDY 
 
The aim of this study was to obtain basic knowledge of the applicability of a spray dryer for 
inhalation particle production and its process parameters effects on particles physicochemical 
properties. From the many process parameters the concentration of the solid substances, inlet 
temperature and concentration of organic solvent were chosen as variables due to their 
apparent effects on product quality and especially on solid state. The greater goal was to provide 
some information about the crystallization tendency of solutes related to chosen process variables. 
The possibility to anneal the particles was also studied. 
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7 MATERIALS AND METHODS 
 
7.1 Materials 
 
Salbutamol sulphate (Fig. 16) is white crystalline powder that is freely soluble in water and 
very slightly soluble in ethanol (Sweetman 2009). However, it is not hygroscopic and 
therefore will not form hydrates (Columbano et al. 2002). Solubility in various ethanol / 
water mixtures decreases almost linearly with the increase of ethanol concentration, reaching 
its lowest value in pure ethanol (Ali et al. 2012). This is in accordance with the observed 
solubility pattern of most salts in ethanol / water mixtures. There are at least two polymorphic 
forms for salbutamol sulphate (Palacio et al. 2007). One polymorph (referred to as type I) is 
obtained when crystallized from water and another (referred to as type II) by resolving a 
methanol crystallized material in methanol and drying it as a suspension in vacuum. The 
extensive use of the racemic salbutamol sulphate as a bronchodilator is somewhat 
questionable considering the fact that the biological effects of different isomers differ 
considerably (Page and Morley 1997). 
 
 
 
Figure 16. Molecular structure of salbutamol sulphate (Ward and Schultz 1995), modified 
from the original. 
 
Budesonide (AstraZeneca) (Fig. 17) is white crystalline powder that is practically insoluble in 
water and sparingly soluble in ethanol (Sweetman 2009). It follows the solubility pattern of a 
weak electrolyte or non-electrolyte and is more soluble in ethanol than water, reaching 
highest solubility around 90% ethanol solutions (Ali et al. 2010). Currently there are no 
known polymorphs for budesonide (Velaga et al. 2002; Steckel et al. 2004; Kubavat et al. 
2012) but different crystalline habits have been produced with different cohesive-adhesive 
balance (CAB) and mechanical properties (Kubavat et al. 2012). 
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Figure 17. Molecular structure of budesonide (Sweetman et al. 2009), modified from the 
original. 
 
 
Micronized salbutamol sulphate was obtained from Letco Meridian Pharmaceuticals, whereas 
micronized and unmicronized budesonide were provided by AstraZeneca DPS (Sweden). 
Solvents used were: ethanol purchased from Kemetyl (Sweden) and, deionized water 
obtained from Millipore (EMD Millipore Corporation, Billerica, MA, USA) water 
purification system. 
 
7.2 Design of experiments 
 
7.2.2 General design 
 
Spray drying is a complex process and there are many factors that can affect the quality of the 
product. There are seven process parameters that are specified by the spray dryer 
manufacturer (Büchi 2012): 
1. Aspirator 
2. The humidity of the drying gas 
3. Inlet temperature 
4. Spray gas flow speed 
5. Feed rate 
6. Concentration of solids 
7. Solvent 
From these parameters concentration of solids (6.), inlet temperature (3.) and concentration of 
organic solvent (7.) were chosen as variables for the conducted experiments. 
 
 
Concentration of solids was chosen as a variable for its effects on solid state (Chidavaenzi et 
al. 1997; Alves and Santana 2004; Bianco et al. 2012; Stieger and Liebenberg 2012), particle 
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size, yield and morphology (Maltesen et al. 2008; Cheow et al. 2010; Amaro et al. 2011). 
The chosen values were relative values in the current solvent mixture in order to maintain 
similar saturation levels and therein similar crystallization tendencies (Stieger and Liebenberg 
2012).  
 
Inlet temperature was chosen as a variable for its effect on solid state (Alves and Santana 
2004; Chiou et al. 2008; Das et al. 2010; Islam and Langrish 2009; Mezzena et al. 2009) and 
humidity (Burnett et al. 2004). The chosen inlet temperature range was chosen on the basis of 
the glass transition temperatures (Tg:s) and the limitations of the used system. This decision 
was based on the suggestion that the crystallization rate would be dependent on the relation 
between the glass transition temperature and the material temperature (Islam and Langrish 
2009). Variation in inlet temperature has also been indicated to contribute to drying 
efficiency (Masters 2002; Alves and Santana 2004).  
 
Concentration of organic solvents was chosen as a variable because of its effects on solid 
state (Harjunen et al. 2002; Gad et al. 2011; Gilani et al. 2005), particle size (Elverssons and 
Millqvist-Fureby 2005a; Bürki et al. 2011) and particle shape (Gad et al. 2011; Kaialy et al. 
2010). The chosen organic solvent was ethanol which, in addition to other effects, has been 
found to improve dispersion properties of the spray dried powder (Gilani et al. 2005). The 
chosen ethanol concentrations in relation to water content were chosen to range from nearly 
equal ratio to higher ethanol concentrations. The width of the range was designed to be a bit 
larger than in Bürki et al. (2011) to allow larger visibility for the differences in process and in 
product quality. The ethanol concentrations used were limited by the solubility data of 
salbutamol sulphate (Ali et al.2012) and budesonide (Ali et al.2010).  
 
The values chosen for the experiments in DOE1 are listed in the Table 2. Air pressure and 
movement in the spray drier is a sum of two components: aspirator value and rotameter value. 
Aspirator provides the air movement for the system and the rotameter is a regulating system 
for the spray gas flow. The aspirator value was chosen to be kept at maximum value (100%) 
in order to provide efficient drying and separation in cyclone (Büchi 2012). The value for the 
rotameter was chosen to represent a rough median of the values used in similar studies 
(Buttini et al. 2008a; Mezzena et al. 2009; Nolan et al. 2009; Tajber et al. 2009a). 
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Table 2. The values and value ranges used in the DOE1 experiments.  
 
    Budesonide Salbutamol 
1. Aspirator (%) 100 100 
2. Humidity drying gas ND ND 
3. Inlet temperature (oC) 80-140 80-100 
4. Spray gas flow (rotameter value) 40 40 
5. Feed rate (%) 17 17 
6. Solids concentration (% of saturation) 50-100 50-100 
7. Organic solvent concentration (%) 50-99.5 40-90 
 
The humidity of the drying nitrogen was not confirmed but it was assumed to be dry (Table 
2).  The Inlet temperature range was designed so that the outlet temperature range would get 
values from below the Tg of salbutamol sulphate (66.7oC, Grisedale et al. 2011) all the way 
over the Tg of budesonide (92oC, Nolan et al. 2009). However, due to the early learning phase 
it was thought that the low boiling point of ethanol (78oC Sweetman 2009) would potentially 
limit the inlet temperature range for safety reasons. This assumption had probably little effect 
on the salbutamol sulphate (low Tg value) and it was later corrected for the budesonide assay. 
The higher concentration (100% saturation, Table 2) was achieved by mixing the solvent 
mixture with excess solids overnight. This mixture was then filtered and spray dried or 
filtered and diluted to produce less saturated solutions. The used feed rate was chosen on the 
basis of other similar studies (Buttini et al. 2008a; Mezzena et al. 2009; Nolan et al. 2009; 
Tajber et al. 2009a).    
 
On the basis of the presented variable choices a factorial design model with the chosen three 
variables (inlet temperature, solids concentration and ethanol concentration) was created. The 
design work was partly done with Modde- software (Umemetrics Academy, 2002). With the 
Modde software the experiments were divided into fractional factorial designs and one these 
was chosen for both test substances. The final chosen fractional factorial design is presented 
in Figure 18.  
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Figure 18. The fractional factorial design. The circled points were chosen to be tested by the 
MODDE 9 -program. 
 
 
7.2.3 Salbutamol sulphate DOE 
 
The DOE1 for salbutamol sulphate was done according to the following fractional factorial 
design (Fig. 18). The measured points are listed in Table 3. The used starting material for 
DOE1 points (Table 3) was micronized and verified to be crystalline by PXRD and sized 1.6 
µm by laser diffraction. 
 
Table 3. Salbutamol sulphate DOE1 points 
 
  CP 1 Point2 Point4 Point5 Point7 Point4b 
Ethanol (%) 70 40 40 90 90 40 
Salbutamol (%) 4 15 7 0.2 - 7 
Tinlet (oC) 91 100 81 80 100 81 
Tout (oC) 52 59 45 54 - 44 
feed speed (%) 17 17 17 17 17 17 
rotameter value 
(spray air flow) 40 40 40 40 40 40 
 
The results from DOE1 were all XRPD amorphous and therefore three further studies were 
designed to increase or clarify the effects of different parameters on crystallinity. First two of 
the studies focused on the effects of the solid concentration in the liquid feedstock (Study I, 
II, table 4) and the third one (Study III, table 4) focused on the effect of temperature. Study I 
was designed to study the different performances of a saturated solution (batch 1, table 4) and 
a suspension that had 10% extra solids (batch 2, table 4) compared to the former one. These 
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values were calculated from the studies presented by Ali et al. (2012). Study II was designed 
to study the different performances of 110% (batch 3, table 4) and 120% suspensions (batch 
4, table 4). 
 
Table 4. The further studies for sabutamol sulphate 
 
  Study I 
 
Study II 
 
Study III 
  Batch Number 1 2 3 4 5 6 7 
Ethanol (%) 40 40 40 40 40 40 40 
Salbutamol (%) 16 17.5 15.1 17.4 12.5 12.4 13 
Tinlet (oC) 101 101 101 101 80 101 141 
Tout (oC) 59 61 61 57 48 57 80 
feed speed (%) 17 17 17 17 17 17 17 
rotameter value 
(spray air flow) 40 40 40 40 40 40 40 
Nozzle cooling 
(oC) - - 15.1 15.1 15.1 15.1 15.1 
 
For Study II an extra element, namely a nozzle cooling system, was introduced to the original 
hardware. Nozzle cooling systems prevents the drying gas induced nozzle heating that might 
affect the solubility of the solute. The nozzle cooling system was introduced because the 
results obtained by Chidavaenzi et al. (1997) had suggested the use in order to further assess 
the results. Study III for salbutamol sulphate was designed to study the effects of temperature 
more precisely. Three similar batches were designed that would wary from each other only 
with their inlet temperatures (batches 5, 6, 7, table 4). Nozzle cooling system was decided to 
be used in these experiments. The conducted studies are listed in Table 4. The used starting 
materials for further salbutamol sulphate studies (Table 4) was micronized and verified to be 
crystalline by PXRD and sized 1.6 µm by laser diffraction. 
 
7.2.4 Budesonide DOE 
 
From all the budesonide DOE1 points only four plus the centerpoint (twice) were produced 
based on the fractional factorial design presented in Figure 18. The measured points are listed 
in Table 4. The variation of budesonide concentration is designed according to the saturation. 
The usage of saturated and half saturated solutions causes the budesonide concentrations to 
look different in the Table 5 due to the changes in budesonide solubility in different ethanol 
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concentrations. The starting material used for budesonide DOE1 points (Table 5) was 
crystalline powder. 
 
Table 5. Budesonide DOE1 points 
 
  CP 1 CP 2 Point2 Point4 Point5 Point7 
Ethanol (%) 75 75 50 50 99,5 99,5 
Budesonide(%) 1.65 1.65 0.6 0.3 2.8 1.4 
Tinlet (oC) 110 111 141 80 81 140 
Tout (oC) 71 68 87 45 53 89 
feed speed (%) 17 17 17 17 17 17 
rotameter value 
(spray air flow) 40 40 40 40 40 40 
Nozzle cooling(oC) 15.1 15.1 15.1 15.1 15.1 15.1 
 
The conclusion of DOE1 was that there were no remarkable differences between the results 
from different test points and that all the test points appear to be crystalline in nature. This led 
to a need to produce XRPD- amorphous product. Literature provides a few similar studies 
that have successfully produced amorphous spray dried budesonide from ethanolic solutions 
(Mezzena et al. 2009; Nolan et al. 2009; Tajber et al. 2009a; Boraey et al. 2012). From these, 
the studies conducted by Nolan et al. (2009) were chosen as the primary guideline (table 6) 
due to the similarities with the used hardware. The further studies conducted were also 
designed to study additional parameters. These were designed to be conducted by producing 
many similar batches where different parameters were varied. The planned parameters that 
would be tested were the spraying air flow (test 2, 4, table 6), raw material quality (test 3, 
table 6) and introduction of additives (test 5, table 6). Of these spraying air flow (Das et al. 
2010) and additives (Stieger and Liebenberg 2012) are noted to affect the crystallinity of the 
material. Different raw material is tested to partly validate the filtering process and test the 
overall differences of different batches. The inlet temperature was kept constant throughout 
further studies as it is clearly indicated to regulate solid state transformation (Mezzena et al. 
2009). 
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Table 6. Budesonide further experiments  
 
  Literature 
 
 This study       
  Nolan Test1 Test2 Test3 Test4 Test5 
Ethanol (%) 95 95 95 95 95 95 
Budesonide(%) 1 1 1 1 2 0.95 
Ascorbic Acid(%) - - - - - 0.05 
Tinlet (oC) 78 78 78 78 78 78 
Tout (oC) 52 47 47 47 50 51 
feed speed (%) 30 30 30 30 30 30 
rotameter value 
(spray air flow) 40 41 55 41 30 40 
Nozzle coolig 
(oC) - - - - - - 
      
  
Starting material microniz. crystall. crystall. microniz. microniz. microniz. 
PXRD crystall. crystall. crystall. crystall. crystall. crystall. 
size (µm), median 1.4 88 88 1.6 1.6 1.6 
 
 
The first experiment (Test 1) was designed to be an exact duplicate of the original experiment 
whereas the rest were modified from the original by varying different parameters (varied 
parameters are shaded grey) (Table 6). Test 2 experiment was based on the assumption that 
smaller droplets would dry much quicker and that there would not be enough time for 
crystallization (Masters 2002). Test 3 was based on the assumption that the original 
dissolution speed of budesonide (Test 1) would be inadequate and leave some minor 
crystalline seeds into the solution. This was tested by changing the raw material into a 
micronized quality. In Test 4 it was checked whether the increase in solid concentration and 
the increase in droplet size would increase the level of crystallinity. Test 5 was based on the 
assumption that additives of similar structure would disturb the crystallization process. 
Ascorbic acid (Fig. 19) was chosen to be the additive because of its similarities in structure 
and solubility. 
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Figure 19. Structure and solubility of ascorbic acid (Rowe et al. 2009) 
 
 
7.3 Preparation of mixtures 
 
The mixtures of ethanol and water were prepared in situ if no commercial products were 
available. The APIs were added after the blending of the solvents and allowed to blend for 
approximately 24 hours which was concluded to be a compromise between the time available 
and the values previously used (Ali et al. 2010). To produce saturated solutions an amount of 
10% excess API was usually added. This precipitated excess API, if included, was filtered 
just prior to the spray drying by using a funnel and filter paper (Munktell analytical filter 
paper, grade 1F, diameter size 150 mm, Munktell Filter AB, Grycksbo, Sweden). If spray- 
dried feeds were intended to be suspensions, the extra solid content was weighted and added 
after filtering. 
 
7.4 Spray drying 
 
All the experiments were conducted with Büchi Spray dryer B-290 (Buchi Labortechnik AG, 
Flawil Switzerland). The used model had a small collection vessel, 1.5mm nozzle cap and 0.7 
mm diameter nozzle but otherwise it was operated with standard equipment provided by 
Büchi. Due to the ethanol content of the feeding mixtures the spray dryer had to be operated 
in closed mode combined with Inert loop B-295 condensation unit (Fryka-Kältetechnik 
GmbH, Esslingen Germany) (Fig. 20). The gaseous drying medium was nitrogen. The system 
used was also later accompanied with a water dispenser (Jumbo F25) to cool down the spray 
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drying nozzle. During the production the spray dryer was situated in a temperature (about 
22oC) and moisture (below 20% RH) controlled laboratory. The used bag filter material was 
insufficient for particle recovery. 
 
 
 
Figure 20. Schematic drawing of a spray dryer combined with inert loop. 
(www.buchi.comTMS, modified from the original)  
 
7.5 Annealing 
 
Some of the spray-dried salbutamol sulphate batches were used to study annealing procedure. 
The goal was to alter the produced round amorphous particles into similarly sized and shaped 
crystalline particles. This was first tried for an amorphous batch (Batch 2 from Study I, Table 
4) in a petri dish for 3 days in a water vapour annealing box of 65% relative humidity. The 
values were chosen on the basis of AstraZeneca´s unreported study (AstraZeneca 2009) but 
they were in good line with the results of Brodka-Pfeiffer et al. (2003). The annealing time 
needed appears to be closely related to the other values used.   
 
After the crude tests, a more elaborate small scale flow-annealing system (Fluxus, 
AstraZeneca, Sweden) was used to anneal salbutamol sulphate. The material used in Fluxus-
experiments was amorphous Batch 7 from Study III (Table 4). The values used in the flow-
annealing system are listed in the Table 6. Due to the intense agglomeration observed in 
Batch 1 (Table 7), slightly lower values were chosen for Batch 2. It was also observed that 
the annealing procedure did not require 48 hours time as observed by Adilovic et al. (2012). 
The new values produced a lot less agglomerated powder, which was unfortunately nearly 
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XRPD amorphous. The conclusion from these results was to increase the temperature and not 
the relative humidity for Batch 3 (table 7). It is known that compared to relative humidity, 
temperature has less effect on particle size in annealing (Brodka-Pfeiffer et al. 2003). 
 
Table 7. The used flow annealing values  
 
  Batch 1 Batch 2 Batch 3 
T (oC) 30 25 30 
RH 60 55 55 
Preheating (h) 2 1 2 
TvapourGenerator 23.4 15.2 19.8 
Drying 1 1 1 
Annealing Time (h) 48 24 13 
turning time: (sec) 8 8 16 
vibration time : (sec) 5 5 10 
vibration delay: (sec) 3 3 6 
sample amount 1.9 2 2.1 
FlowVapourGener (l/min) 0.5 0.5 0.5 
 
Budesonide annealing was conducted for batch test 3 (Table 6). Small amount of material 
from batch test 3 was applied to two XRPD-plates. These plates were first measured with 
XRPD and then put in two different annealing boxes. The other box contained ethanol salt 
solution that corresponded to 74% relative ethanol activity and the other box contained 
solution that provided 100% relative ethanol activity. The samples were measured five times 
at different time intervals (0, 1st, 4th, 7th and 16th day). The raw materials (Crystalline raw 
material and micronized raw material) were used as control samples and they were put in the 
100% relative ethanol activity box. The control samples were measured four times (0, 1st, 4th 
and 13th day) 
 
7.6 Characterization 
 
7.6.2 Particle size distribution 
 
Particle size distribution was analyzed with laser diffraction (Mastersizer 2000, Scirocco 
2000, Model MS2000, Malvern Instruments, Worcestershire UK) using a dry powder 
method. A small amount of powdered sample (less than 1 g) is introduced to the analyzer by 
using the scirocco attachment. Air pressures from 1 to 3 bars were tested to validate a suitable 
pressure for repeatable tests for each sample. Three parallel tests were done when the sample 
amount was adequate.  The feed rate for the powder was varied from 10 mm/s to 50mm/s 
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depending on the powder flowability. The measured D10, D50 and D90 values were reported 
and in addition the Span was calculated according to the Equation 3.  
 
               
  𝑆𝑝𝑎𝑛 = 𝐷90−𝐷10
𝐷50      (3) 
 
 
7.6.3 Crystallinity 
 
The X-ray powder diffraction (XRPD) patterns for the samples were analyzed with 
Diffractometer D8 (Bruker AXS, Karlsruhe, Germany, PXRD1) and with Philips 
PANalytical X´Pert (PXRD2). The PXRD1 was used for all other analyses, save the ethanol 
atmosphere annealing studies for budesonide. This was due to the inherent intolerance of the 
sample holders in the PXRD1 for ethanol atmosphere. A small amount of the samples 
measured were carefully spread into individual sample holders. The measurements were 
generally carried out immediately after the production. 
 
The Bruker AXS Diffractometer D8 (PXRD1) was operated with a position sensitive detector 
(PSD) LynxEye with a 3° PSD-window. The Cu anode X-ray tube was operated at 30 kV and 
50 mA. Measurements were generally taken from 2.4◦ to 50◦ with a step size of 0.02 (◦2 
Theta) and a dwell time of 0.5 s per step. Sample holders were made of plastic with a silicon 
plate. 
 
The Philips PANalytical X´Pert (PXRD2) was operated with a 1.0◦ dispersion slit and a 0.1◦ 
receiving slit. The Cu anode X-ray tube was operated at 45 kV and 40mA. Measurements 
were generally taken from 2.4◦ to 50◦ with a step size of 0.013 (◦2 Theta). The measuring time 
was 44.37 sec. Sample holders were assembled from a silicon plate and a steel ring before 
measurements. These sample holders contained no glue or plastic and were able to withstand 
organic solvents like ethanol. 
 
7.6.4 Particle morphology 
 
The morphology of each sample was studied using a scanning electron microscope, SEM, 
(Quanta 200, FEI Company, Eindhoven, The Netherlands) at high vacuum mode. Images 
were taken from random locations. Prior to imaging, a small amount of each sample was 
dispersed on a carbon sticky tab and coated with gold. The thin gold coating was applied on 
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the surface with a sputter coater (108 auto sputter coater, Cressington scientific instruments 
Ltd, Watford, UK) in argon atmosphere at 20 mA for 100 seconds. 
 
 
8 RESULTS AND DISCUSSION 
 
8.2 Raw materials 
 
The raw materials used, two types of budesonide and one type of salbutamol sulphate, were 
characterized by using the same measurement techniques as for the products. These included 
PXRD, SEM and laser diffraction. 
 
8.2.2 Particle size distribution 
 
Particle size distribution (Table 8) was quite similar in both micronized batches, whereas the 
crystalline batch was considerably larger sized. The micronized quality is within the 
respirable size range (Newman et al. 2009). 
 
 
Table 8. Particle size distribution of APIs  
 
    D10 (µm) D50 (µm) D90 (µm) 
Salbutamol sulphate 0.7 1.5 3.1 
Budesonide 
 
9.7 88.7 254 
Budesonide, micronized 0.5 1.6 3.8 
 
 
8.2.3 Crystallinity 
 
The PXRD studies for budesonide show a typical crystalline pattern (Phamand and 
Wiedmann 2000; Steckel et al. 2004; Mezzena et al. 2009; Naikawade et al. 2009; Nolan et 
al. 2009; Tajber et al. 2009a; Kumon et al. 2010; Carr et al. 2011; Boraey et al. 2012; 
Kubavat et al. 2012) (Fig. 21). The differences in peak intensities can possibly be explained 
by the presence of amorphous material in the micronized raw material (Fix and Steffens 
2004; Grisedale et al. 2011) or size differences (Grisedale et al. 2011). 
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Figure 21. XRPD diffractograms of budesonide raw materials. The black line is crystalline 
budesonide (D50=88.7µm) and the red line is micronized crystalline budesonide (D50=1,6µm)  
 
The PXRD pattern of the used salbutamol sulphate was also crystalline (Chawla et al. 1994; 
Ward et al. 1995; Columbano et al. 2002; Palacio et al. 2007; Palacios et al. 2007; Raula et 
al. 2008; Balani et al. 2009; Dhumal et al. 2009; Balani et al. 2010; Grisedale et al. 2011; 
Mueannoom et al. 2012; Traini et al. 2012). It is good to acknowledge, however, that it was 
micronized and therefore might contain partly amorphous material (Grisedale et al. 2011) 
(Fig. 22). This XRPD pattern resembles closely form I polymorphic type characterized by 
Palacio et al. (2007). 
 
When interpreting XRPD patterns it is necessary to acknowledge the limits of the method 
used. The XRPD has been verified to detect less than 1% amorphous contents in crystalline 
solids (Chen X. et al. 2001; Fix and Steffens 2004) and less than 0.5% crystalline content in 
amorphous solids (Fix and Steffens 2004). These results are dependent on the optics and the 
sample preparation technique used. In addition to these limitations it is good to keep in mind 
that similar XRPD pattern can be produced by different solid state forms of the same 
substance (Bates et al. 2006) or two totally different substances (Brittain 2003). It is therefore 
suggested that another confirming technique like differential scanning calorimetry (DSC) 
should be used to verify XRPD results (Brittain 2003).  
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Figure 22. XRPD diffractograms of salbutamole sulphate raw material.  
 
Annealing the budesonide raw materials in 100% REtOH atmosphere and room temperature 
(22oC) for 120h did not change the XRPD profile remarkably, but slightly bigger changes can 
be observed in the peaks of the micronized batch (data not shown). These results support the 
measurements done by Grisedale et al. (2011). 
 
8.2.4 Morphology 
 
Particle size differences can be easily detected from the SEM pictures of budesonide raw 
materials (Fig. 23). Figure 23 also suggest that the unmicronized budesonide could be 
crystalline but this needs to be confirmed with additional measurement techniques. 
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Figure 23. SEM pictures of unmicronized budesonide raw material (left) and micronized 
budesonide raw material (right).  
 
8.3 Salbutamol sulphate DOE1 
 
The points listed in Table 3 were the points that were designed to be measured. However, due 
to the technical challenges and the early learning phase it later became evident that not all the 
designed points were feasible. Due to these challenges point 4 was repeated (Point 4b) and 
point 7 had to be excluded from the planned experiments. Challenges that were encountered 
for the production of point4 were the apparent total blocking of the bag filter in the early 
phase of the spray drying and the overestimation of the product yield. As the research went 
further it became evident that the product yield for the point 7 would be considerably low due 
to the low yield recovered from the point 5 that had two times higher solid content. 
 
8.3.2 Yield 
 
The yields for the salbutamol sulphate DOE1results (Table 9) are quite varying. The reasons 
for this are the two challenges pointed out in the previous chapter and the variation in the 
solubility of the salbutamol sulphate in different solvent mixtures. Point2 (Table 9) which 
gave a reasonable yield, was produced from a saturated solution and from a solvent mixture 
to which salbutamol sulphate had a good solubility. The successfully produced batch 4 (Point 
4b) emphasizes the fact that one must have large enough batches to minimize the relative 
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effects of some of the major factors that decrease the yield: deposition in the walls of the 
spray drier and adsorption in the surface of the bag filter. 
 
Table 9. Salbutamol sulphate DOE1 yields  
 
  Yield (g) Yield (%) 
Point2 0.88 27 
Point4b 2.7 66 
Point5 0.14 9 
CP1 0.16 7 
 
 
8.3.3 Particle size distribution 
 
From the results presented in Table 10 the only viable candidate for further development 
seems to be Point4b because it has the particle size distribution closest to the 1-5 µm particle 
size that is considered essential for deep lung penetration (Bechtold-Peters et al. 2007). The 
small yields (Table 9) affected the credibility of the particle size measurements (Table 10) 
due to the lack of decent amount of parallel samples.  The high D90 values (Table 10) are 
caused by an attempt to improve low yields by recovering material that had fused in the walls 
of the cyclone. This material was effectively fused with cyclone and had to be mechanically 
recovered in considerably large particles. 
 
Table 10. Salbutamol sulphate DOE1 particle size distribution  
 
  D10 D50 D90 Span 
Point2 0.95 4.2 150 36 
Point4b 0.74 2.7 5.7 1.8 
Point5 0.6 6.9 89 13 
CP1 0.7 2.6 80 31 
 
8.3.4 Crystallinity 
 
Figure 24 shows that the spray dried batches for salbutamol sulphate DOE1 were all 
amorphous in XRPD. This finding that all the produced batches were amorphous confirms 
the conclusion that the batch point 4 (table 3) was the best candidate for further studies under 
these circumstances with its superior yield and suitable size distribution compared to other 
batches. 
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Figure 24. XRPD diffractograms of salbutamol sulphate DOE1 batches  
 
8.4 Salbutamol sulphate -effects of temperature and concentration 
 
8.4.1 Yield 
 
From the results (Table 11) we can conclude that the yield percentage increases slightly when 
the raw material amount is increased. There are no significant differences between the 
relative yields for different batches. These yields can be considered reasonably high 
according to literature (Bögelein and Lee 2010). 
 
Table 11. The further studies yield for salbutamol sulphate  
 
  Yield (g) Yield (%) 
1 (I) 5 87 
2 (I) 7.1 92 
3 (II) 4.9 79 
4 (II) 5.3 79 
5 (III) 6.6 86 
6 (III) 8.7 89 
7 (III) 8.9 81 
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8.4.2 Particle size distribution 
 
It can be seen that for Studies I and II (table 12), the excess solid content seems to have 
increased the particle size. Similar results are found in other studies (Elversson et al. 2003; 
Corrigan et al. 2004; Mosen et al. 2004; Elversson and Millqvist-Fureby 2005a; Maury et al. 
2005; Sansone et al. 2009; Amaro et al. 2011; Gallo et al. 2011; Buchi process parameters 
guide 2012). The same phenomenon is also seen in Study III but now the particle size has 
increased in the function of the inlet temperature. In the literature size variation in particle 
size is said to increase (Fang et al. 2012) but the effects on particle size are mixed. The 
increase in temperature was found to increase particle size by Fu et al. (2013) but not by 
Maas et al. (2011). These results could indicate that temperature has a substance specific 
effect on particle size. 
 
Table 12. Particle size distribution for further studies  
 
  D10 (µm) D50 (µm) D90 (µm) Span 
1 (I) 0.65 2.6 5.9 2 
2 (I) 0.73 2.9 6.8 2.1 
3 (II) 0.64 2.5 6.2 2.2 
4 (II) 0.64 2.8 7 2.3 
5 (III) 0.56 2.2 5.6 2.3 
6 (III) 0.58 2.3 5.7 2.3 
7 (III) 0.72 2.8 6.5 2.1 
 
8.4.3 Crystallinity 
 
The salbutamol sulphate batches from Study I were both amorphous and there were no 
significant differences between the two batches (Fig. 25). These results suggest that the 
product is not sensitive to the composition of the feedstock in regard to the solid content. 
Therein it does not support the findings of Alves and Santana (2004) and Bianco et al. 
(2012). Batch 1 (Fig. 25) was produced by spray drying a saturated solution and Batch 2 (Fig. 
25) was produced from the same saturated solution with 10% added excess solid to form a 
suspension. Spray drying seems to convert suspended material into the amorphous state in 
addition to the dissolved material. This finding was also observed by Chidavaenzi et al. 
(1997), who suggest the reason for this phenomenon to be pressure induced milling effect and 
excess nozzle heating that together increase the apparent solubility.   
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Figure 25. XRPD diffractograms of salbutamol sulphate Study I, Batches 1 and 2  
 
The results in Figure 26 prove that the phenomenon was at least partly dependent on nozzle 
temperature as presented by Chidavaenzi et al. (1997). The results also show that the peaks 
were higher in the product that was produced from higher solid content suspension but not as 
high as in original raw salbutamol sulphate (Fig. 22). This could indicate that the spray 
drying process does not considerably increase the amorphicity of the suspended material 
when nozzle cooling is used. This is probably due to two reasons: firstly precipitation is 
energetically more favorable state than high supersaturation (Stieger and Liebenberg, 2012) 
and secondly the suspended crystalline material is energetically more stable than amorphous 
material. Therefore, if the solubility remains unchanged the excess solid material will be little 
affected. The higher peaks for the Batch 4 (Fig. 26) could probably be caused by the larger 
quantity of the suspended material and by the observed larger particle size (table 12) as 
pointed out by Grisedale et al. (2011).  
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Figure 26. XRPD diffractograms of salbutamol sulphate study II, Batches 3 and 4  
 
The results (Fig. 27) show that there were no significant differences in the crystallinity of 
these three batches when measured with XRPD. This is interesting as Islam et al. (2010) 
found that temperature might increase crystallinity. Perhaps the temperature range was 
inadequately narrow or crystallinity is more dependent on material than on process 
parameters.   
 
 
 
Figure 27. XRPD diffractograms of salbutamol sulphate further Study III, Batches 5, 6 and 7  
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8.4.4 Morphology 
 
Figure 28 shows that the spray dried salbutamol sulphate particles in Batch 2 (Study I, table 
4) were round, smooth and about 5 µm in diameter. Figure 29 shows that both samples in 
Study II (table 4) were similarly structured and sized as particles in Study I (table 4). 
 
 
 
Figure 28. SEM pictures of salbutamol sulphate Batch 2 from Study I (table 4)  
 
 
 
Figure 29. SEM pictures of salbutamol sulphate Batch 3 (left) and Batch 4 (right) from the 
Study II (table 4)  
 
Study III (Fig. 30) produced similarly round particles around size 5 µm diameter as Study I 
(Fig. 28) and II (Fig. 29). There can, however, be slight differences observed between the 
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highest (Batch 7) and the lowest (Batch 5) inlet temperature batches. Some of the particles in 
Batch 5 (Fig. 30) seem not to have a smooth surface but a quite wrinkled instead. This may 
indicate that the lower drying temperature has allowed the samples to dry slower, shrink in 
size and form dense particles (Masters 2002) with larger surface area. This conclusion is not 
entirely supported by literature because Littringer et al. (2012), Fang et al. (2012) and Maas 
et al. (2011) produced opposite results. Most probably the results are dependent on the 
characteristics of the spray-dried substance. 
 
In Study III (Fig. 30) the higher inlet temperature has produced smooth particles with 
possibly lower density, hollow structure and less durability for mechanical handling (Masters 
2002). Though the temperature seemed not to affect crystallinity, it had some interesting 
effects on the morphology of the particles that might be useful for inhalation formulations. 
More corrugated particles have been found to produce more fines during the inertial 
impaction when compared with smoother particles (Adi et al. 2013). Larger surface area 
would also possibly provide faster dissolution time and on the other hand hollow particles 
would be beneficial as phagocytic clearance in the lungs needs to be avoided (Bechtold-
Peters et al. 2007, Newman et al. 2009).  
 
 
 
Figure 30. SEM pictures of salbutamol sulphate Batch 5 (left) and Batch 7 (right) from the 
Study III (table 4)  
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8.5 Salbutamol sulphate annealing 
 
8.5.1 Crude annealing in a box 
 
Spray dried salbutamol sulphate that was initially amorphous powder had turned into larger 
agglomerates that had partly stuck on the surface of the annealing dish. The particle growth 
was verified with particle size measurements (Table 13) and crystallinity with XRPD (Fig. 
31). 
 
Table 13. Particle size distributions for spray dried and annealed  
salbutamol sulphate batch. 
 
  D10 D50 D90 Span 
SBS Spray dried (µm) 0.73 2.9 6.8 2.1 
SBS Annealed (µm) 360 970 1600 1.3 
 
 
 
 
Figure 31. XRPD diffractograms of salbutamol sulphate annealed with the crude method.  
 
The SEM pictures (Fig. 32) confirm the particle size growth noted in the particle size 
distribution measurements (Table 13). Particle growth in annealing has previously been 
recognized by Brodka-Pfeiffer et al. (2003), who also found it rather challenging to avoid. 
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The left part of Figure 32 shows that the particle has been damaged and seems to have two 
distinctly different regions: surface and core. This finding could indicate that these annealed 
particles are not hollow. It also raises a question whether the two regions are equally 
crystalline and formed of the same polymorph. The damage for the particle in left side of the 
Figure 32 is probably caused by the necessary detaching of particles from the annealing dish.  
 
The conclusion from this crude annealing method was that fully XRPD amorphous 
salbutamol sulphate can be annealed to a XRPD crystalline form in three days time under the 
used conditions. The challenges are the uncontrolled particle growth and the process 
dependency on different variables. 
 
 
 
Figure 32. SEM pictures of annealed salbutamol sulphate particles, one particle (left), 
overview (right).  
  
8.5.2 The utilization of small scale flow annealing equipment 
 
The result for the Batch 1 annealing was XRPD crystalline agglomerate (Fig. 33) with little 
or no powder. The changes made for Batch 2 (table 6) produced a lot less agglomerated 
powder, which was unfortunately nearly XRPD amorphous (Batch 2, Fig. 33). These results 
were thought to be caused by too low process temperatures in Batch 2. Though this was 
proven wrong with the Batch 3, what produced tightly aggregated non-crystalline material in 
higher temperature (Batch 3, Fig. 33). The reason for the quality produced in Batch 3 might 
be related to the less intense mechanical handling (slower turning time, table 7) that might 
have limited the mixing efficiency of the processed powder.  
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Figure 33. XRPD diffractograms of salbutamol sulphate in flow annealed samples  
 
8.6 Budesonide DOE1 
 
8.6.1 Yield 
 
The DOE1 batches of budesonide were all less than 3 g each. This, the cohesive nature of 
budesonide (Boraey et al. 2012) and the small particle size caused the yields (Table 14) to 
remain small. Varying amounts of product ended in the top of the cyclone and into the bag 
filter. Due to the current setup they were not harvested (the top of the cyclone was hard to 
reach and the used bag filter type was not designed for collecting purposes). The low yield in 
spray drying pure budesonide powders can be a challenge (Boraey et al. 2012) and should 
therefore be anticipated.   
 
 
 
 
 
 
 
 
 
 
0
5000
10000
15000
20000
25000
0,00 5,00 10,00 15,00 20,00 25,00 30,00 35,00 40,00
Li
n 
(C
ou
nt
s)
 
2-Theta-Scale 
Batch1
Batch 2
Batch 3
69 
 
Table 14. Budesonide DOE1 yields  
 
  
Yield 
(g) Yield (%) 
Point2 0.34 27 
Point4 0.44 17 
Point5 0.66 23 
Point7 0.24 17 
CP1 0.25 24 
CP2 0.46 34 
 
The highest yield in grams (Point 5) is partly explained by the good solubility of budesonide 
in saturated solution at this point (Table 14). Apparently the half saturated points (Point 4 and 
Point 7) have lower yield percentages than the saturated points (Point 2 and Point 5). This 
might also be the result of the lower initial solid content. 
 
8.6.2 Particle size distribution 
 
Particle size distribution for the budesonide DOE1 batches are listed in Table 15. The low 
yields and especially the bag filter blocking might indicate a larger amount of smaller size 
fractions in the product than measured with laser diffraction. For the lower yield the material 
had to be scratched from the surfaces of the cyclone and the main collection vessel. This may 
have affected the quality of the products. The amounts produced were also inadequate for 
particle size measurements, because they did not provide enough material for many parallel 
measurements. The results in Table 15 show a trend where the chosen three parameters 
(ethanol concentration, inlet temperature and solid content) seem to have little effect on the 
particle size and particle size distribution. The deviation of the D90 value for point7 might be 
explained by agglomerates produced by scratching the material from the glass surfaces. 
Further studies are needed to confirm this. 
 
Table 15. Budesonide DOE1 particle size distribution  
 
  D10 D50 D90 Span 
Point2 0.79 1.3 2.1 1 
Point4 0.48 1.2 2.9 2 
Point5 0.79 1.5 2.6 1.2 
Point7 0.64 1.6 43.2 26.6 
CP1 0.77 1.4 2.3 1.1 
CP2 0.79 1.4 2.3 1.1 
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8.6.3 Crystallinity 
 
The XRPD diffractogram of the budesonide DOE1 products are presented in Figure 34. The 
pattern of each produced batch resembles closely the crystalline pattern of the raw material 
(Fig. 21, crystalline budesonide). The differences in the peak heights may be a sign of 
amorphous content in the spray dried batches (Fix and Steffens 2004; Grisedale et al. 2011).  
 
From Figure 34 it can be observed that the lowest peaks were in the batches Point2 and Point 
4 and the highest peaks were in the batches Point 7 and CP 2. The high peaks in point 7 could 
partly be the result of larger observed particle size (table 15) (Grisedale et al. 2011), although 
this claim is not supported by the particle size results for CP2 (table 15). Both the lowest 
batches had the lowest ethanol concentration and lowest solid content when compared with 
the others. This may be explained by the fact that ethanol concentration and low solids 
concentration have both been indicated as variables that could alter the crystal development 
(Stieger and Liebenberg 2012) in a rapid process like spray drying (Masters 2002). 
 
The solid state properties dependency on the inlet temperature used in spray drying (Mezzena 
et al. 2009) is challenged by the results from point 4 and point 2 that had similar results but 
different inlet temperatures (Table 4). No other polymorphs seem to be present in these 
batches (Velaga et al. 2002; Steckel et al. 2004; Kubavat et al. 2012). 
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Figure 34. XRPD diffractograms of budesonide DOE1 batches.  
 
The seemingly crystalline nature of the spray dried budesonide (Fig. 34) is not in line with 
the studies conducted by Nolan et al. (2009) who produced amorphous budesonide with a 
spray dryer under similar conditions. This is somewhat surprising considering the differences 
between their non-porous budesonide particle production (Nolan et al. 2009) and the 
produced point 5 (Table 4). The main differences noted are the nozzle cooling system, 
different budesonide concentration, different raw material quality and different feed speed. 
However, there is some evidence that most of these differences might increase crystallinity.  
The nozzle cooling system will lower the temperature of the feed and thus lower the 
solubility of budesonide (Mota et al. 2009) and increase crystallization (Stieger and 
Liebenberg 2012). To combine the lowering of temperature with higher budesonide 
concentration even increases the crystallization tendency. The slower solubility of larger raw 
material might have left some unsolved material into the solution that had acted as seeds for 
crystallization (Stieger and Liebenberg 2012). Unlike the others, the slower feeding might 
have decreased the crystallinity by shortening the drying period (Masters 2002). The 
combined effect of these parameters is challenging to define due to the interactions between 
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different parameters that only emphasize the complexity of the spray drying process (Amaro 
et al. 2011). 
 
8.6.4 Morphology 
 
The individual spray dried budesonide particles from DOE1 seem to be round and apparently 
loosely aggregated together (Fig. 35) judging from the figure and from the particle size 
distribution data. These types of loosely aggregated small round particles might be beneficial 
in the DPI (Newman et al. 2009). 
 
 
 
Figure 35. SEM pictures of spray dried budesonide from DOE1 (point 4, Table 4)  
 
8.7 Further studies on budesonide 
8.7.1 Yield 
 
From the yields of the further studies (Table 16) it is clearly noted that the lowering of the 
spray gas flow (rotameter value) increases the yield. This is, interestingly, exactly an opposite 
result when comparing with literature (Goula et al. 2005; Amaro et al. 2011). These results 
might be caused by the increase in spray droplet size (Masters 2002). This larger droplet 
would have more material in it and therefore it would dry to larger particles. These larger 
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particles are more efficiently captured in the cyclone which is ineffective in capturing the 
smallest size fractions. 
 
Table 16. Budesonide further studies yields 
 
  Yield (g) 
Yield 
(%) 
Test1 4.1 41 
Test2 3.1 31 
Test3 2.2 22 
Test4 8.4 82 
Test5 2.1 21 
 
8.7.2 Particle size distribution 
 
From the particle size data (Table 17) it is clearly noted that Test 4 result are slightly different 
from others. All the experiments are mainly within the inhalable range (1-5 µm). The poor 
yields in Test 1-3 and the observed blocking of the bag filter might have altered the results 
for the finer fractions. 
 
Table 17. Budesonide further testing particle size distribution 
 
  D10 D50 D90 Span 
Test1 0.82 1.4 2.4 1.1 
Test2 0.72 1.3 2.1 1.1 
Test3 0.76 1.3 2.1 1 
Test4 0.55 2.2 5.1 2.1 
 
8.7.3 Crystallinity 
 
The crystalline form was similar in all four batches, (Fig. 36 and 37). However, some 
differences in the peak heights were noted. Previous studies have shown that higher peaks 
could be an indication of higher crystallinity (Fix and Steffens 2004; Grisedale et al. 2011) or 
larger particle size (Grisedale et al. 2011). This is particularly interesting for different 
samples in Test5 (Fig. 37) as it seems that material that has not adhered to the walls of the 
sample container might be more crystalline. According to this the harvesting place from spray 
dryer could affect the solid state form of the product. The experiments conducted by Islam 
and Langrish (2010) support these findings by suggesting that the wall deposition in the spray 
dryer could affect the solid state of the product but not necessarily the level of crystallinity. 
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There is also evidence that a major part of crystallization could in some cases take place in 
the walls of the spray dryer (Islam and Langrish 2009).  
 
The usage of different drying and spraying gases could have explained this crystallinity as 
Nolan et al. (2009) used atmospheric air to create amorphous budesonide and in this study 
crystalline budesonide was dried with nitrogen. The effects of different gas types in spray 
drying is supported by Islam et al. (2010b) and Bianco et al. (2012), but the results obtained 
by Mezzena et al. (2009) strongly challenge this effect. In addition the purity and solvent 
vapour content of the new and recycled gases remain largely uncharted (Bianco et al. 2012). 
Solvent vapour traces could alter the solubily of substances and powder traces could act as 
nucleation centers contributing to crystallization (Stieger and Liebenberg, 2012). 
 
 
 
Figure 36. XRPD diffractograms of further budesonide testing points 1-4. 
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Figure 37. XRPD diffractograms of further budesonide testing point 5. Test 5a and 5b 
represent samples that have been collected with different means. Test 5a was poured to the 
sample container from the spray dryer’s product vessel and the Test 5b was the remaining 
material that had to be scratched out from there.  
 
8.7.4 Morphology 
 
The SEM pictures from the test batches 1-4 (Fig. 38) indicate that the particles are round and 
to some extent aggregated to each other. These pictures seem to support the laser 
diffractometer results that the particle size is within the inhalable range (1-5 µm).  The 
finding that the test 4 batch is larger sized than the three others is also supported by Figure 
38. This could also be the reason for higher peaks in Figure 36 (Grisedale et al. 2011). 
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Figure 38. SEM pictures of the budesonide test Batches 1-4. Upper left corner Test 1, Upper 
right corner Test 2, lower left corner Test 3 and lower right corner Test 4. 
 
8.8 Annealing of budesonide 
From Figure 39 and 40 it can be seen that the peaks have elevated and that the valleys have 
become deeper. A small elevation of peaks can also be seen for the controlling material (data 
not shown). According to the research done by Fix and Steffens (2004) and Grisedale et al. 
(2011) this may indicate an increase in crystallinity or in particle size (Grisedale et al. 2011). 
A small difference is also seen between the micronized and unmicronized controlling samples 
(data not shown) indicating possibly the production of amorphous material in micronization 
process. 
 
A difference can also be observed in the speed of crystallization when comparing Figure 39 
and 40. The higher ethanol activity has fully crystallized the sample in 4th day measurement, 
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whereas in the lower ethanol activity the process has continued till the 16th day measurement. 
These differences indicate that higher ethanol activities increase the speed of the process. 
 
 
 
Figure 39. XRPD diffractograms of Test 3 budesonide batch annealed in 74% ethanol 
activity. 
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Figure 40. XRPD diffractograms of Test3 budesonide batch annealed in 100% ethanol 
activity. 
 
From the annealing results for Batch Test3 it can be concluded that this spray dried batch 
altered in annealing process. This can be observed from the altered X-ray diffractograms 
(Fig. 39 and Fig 40). The change in annealing process is mostly a combination of increased 
crystallinity and increased particle size as observed by Brodka-Pfeiffer et al (2003). 
Unfortunately the current setup does not allow monitoring of the particle growth. The 
conclusion is that the spray-dried material was not totally crystalline during the first X-ray 
measurements. Further studies need to be conducted in order to define the relative 
contribution of particle size growth and increase in crystalline material to the results 
respectively. 
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9 CONCLUSIONS 
 
Both model substances were successfully spray dried. Spray dried salbutamol sulphate turned 
out to be amorphous and budesonide turned out to be crystalline. Both products were within 
the inhalable size range (1-5 µm). The yields varied a lot due to the apparent dependencies on 
process parameters and material properties. The use of very small batch sizes should be 
avoided to maximize yield percentage and to provide more usable material for analysis.  
 
The effects of the solid concentration on the product quality seem to be limited on the 
increased yield, particle size and partly on increased crystallinity. The increased crystallinity 
is due to the solubility exceeding solid content and the formation of suspension. This is 
confirmed by the usage of nozzle cooling system that prevents the heating up of the solution 
and therein prevents an increase in solubility in the nozzle. The effects on particle size are 
somewhat mixed but the trend is that an increase in concentration of solids will increase 
particle size. An increase in the concentration of solid substances increased the yield notably. 
An increase in inlet temperature may increase particle size and decrease surface roughness 
but seems not to affect the level of crystallization. Particles with high surface roughness 
could potentially be beneficial due to their aerodynamic properties if the process could be 
properly controlled. The effects of the used ethanol/water ratios were mostly on yield due to 
the solubility changes for the test substances. The increased solubility on the used solvent 
mixtures increased yields when saturated solutions were used. The used ethanol/water ratios 
seemed to have no effect on the solid state of the products. Of the other tested variables 
(Spray air flow, raw material quality and the addition of additives) only spray air flow 
seemed notably to affect the product within the variable ranges used. A decrease in spray air 
flow seemed to increase yield and particle size. This may be due to more efficient capturing 
of the larger particles in the cyclone.  
 
The somewhat mixed results in the effects of the used variables are partly due to dependency 
of the results on the nature of different substances and partly due to the interactions between 
different variables. These things cause the spray drying process to be a versatile method that 
requires careful design of experiments. 
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Spray dried amorphous salbutamol sulphate was successfully annealed into a crystalline 
material and partly crystalline budesonide was annealed to a possibly more crystalline state. 
The kinetics of the annealing procedure still remains largely unexplored as well as the factors 
associated with it. The problematic size growth associated with annealing was noticed in part 
of the batches. Due to the sample preparation and measurement techniques used the effect of 
particle growth could not be verified in all samples. 
 
Future studies with spray dryers could be focused on budesonide as it interestingly produced 
crystalline particles within the inhalable particle size range. The dependency of the solid state 
of spray dried budesonide on the used spraying and drying gases could be studied more 
closely. In addition the dependency of the surface roughness on temperature of the spray 
dried salbutamol sulphate particles should be studied more. They could also be tested in an 
inhalator. In annealing the dependency of particle size growth in Fluxus on humidity and 
temperature should be studied more closely. 
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